Update May 25 - May 31, 2020, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 22 2020 709 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker AAN - Neurology resources COVID-19 resources (Harvard) COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF)

COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database

Mainstream Media U.S. plans massive coronavirus vaccine testing to meet year-end deadline (Reuters) Japan's 3 Cs”—closed spaces, crowds, and close-contact settings (Science) Alzheimer’s Gene (E2/E2) Linked to Higher Risk of Severe COVID-19 (Scientist) COVID-19 Vaccine Researchers Mindful of Immune Enhancement (Scientist) Hydroxychloroquine study questioned by 120 researchers (Guardian) The World Is Still Far From Herd Immunity for Coronavirus (NYT) What’s the Risk of Catching Coronavirus From a Surface? (NYT) Masks helped keep Japan's COVID-19 death toll low, says expert panel There will probably be a second wave (Guardian) Death threats after a trial on chloroquine for COVID-19 (Lancet) genomics to help avoid a second coronavirus wave (Nature) Ethical guidelines for COVID-19 tracing apps (Nature) It’s Not Whether You Were Exposed to the Virus. It’s How Much (NYT) Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere (Scientist) Researchers Applaud Spanish COVID-19 Serological Survey (Scientist) Genetic risk factors for Alzheimer’s also raise the risk of getting COVID-19 (Science) How to Improve and Protect Nursing Homes From Outbreaks (NYT) Karl Friston: 'Germany may have more immunological “dark matter” (Guardian)

KeyArticles

1. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS- CoV-2. Viruses 2020; 12Younes N, Al-Sadeq DW, Al-Jighefee H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466458

2. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia. J Med Virol 2020; Wang CZ, Hu SL, Wang L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470167

3. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study. Circulation 2020; Szekely Y, Lichter Y, Taieb P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469253

4. Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. Am. J. Epidemiol. 2020; Risch HA. http://www.ncbi.nlm.nih.gov/pubmed/? term=32458969

5. Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring. J Am Heart Assoc 2020:e017144Ramireddy A, Chugh H, Reinier K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463348

6. COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns. Pain Ther 2020; Pergolizzi JV, Jr., Varrassi G, Magnusson P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447629

7. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system. Eur Heart J Cardiovasc Pharmacother 2020; Offringa A, Montijn R, Singh S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464637

8. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID- 19 Crisis. Int J Environ Res Public Health 2020; 17Mirabelli M, Chiefari E, Puccio L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456064

9. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr. Metab. Cardiovasc. Dis. 2020; Li M, Dong Y, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456948

10. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab 2020; Korakas E, Ikonomidis I, Kousathana F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459524

11. Predictors for Severe COVID-19 Infection. Clin Infect Dis 2020; Bhargava A, Fukushima EA, Levine M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32472676

12. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J. Thromb. Thrombolysis 2020; Artifoni M, Danic G, Gautier G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451823

Basic Science (23 articles)

1. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19. Aging (Albany NY) 2020; 12Menendez JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463794 2. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization. Biochem. Biophys. Res. Commun. 2020; Bongini P, Trezza A, Bianchini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451080 3. Stability of RNA sequences derived from the coronavirus genome in human cells. Biochem. Biophys. Res. Commun. 2020; Wakida H, Kawata K, Yamaji Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32446559 4. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines 2020; 8Glinsky GV. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455629 5. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br. J. Pharmacol. 2020; Cleary SJ, Pitchford SC, Amison RT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462701 6. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling. Clin Infect Dis 2020; Zhang H, Ai JW, Yang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463434 7. Physicochemical properties of SARS-CoV-2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control. Electrophoresis 2020; Scheller C, Krebs F, Minkner R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469436 8. SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020. Emerg Infect Dis 2020; 26Bartolini B, Rueca M, Gruber CEM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459984 9. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp. Mol. Pathol. 2020:104474Lavi E, Cong L. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454103 10. High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. Int. J. Biol. Macromol. 2020; Naik B, Gupta N, Ojha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470577 11. ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19. J Allergy Clin Immunol 2020; Bradding P, Richardson M, Hinks TSC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450087 12. Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment. J Biomol Struct Dyn 2020:1-16Ahmad S, Abbasi HW, Shahid S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462996 13. Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs. J Biomol Struct Dyn 2020:1-11Amin M, Abbas G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469265 14. Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease. J Biomol Struct Dyn 2020:1-15Choudhury C. http://www.ncbi.nlm.nih.gov/pubmed/? term=32452282 15. Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn 2020:1-27Kumar V, Dhanjal JK, Bhargava P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469279 16. Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics. J Clin Med 2020; 9Kaden R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466577 17. Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19. Life Sci 2020:117842Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454157 18. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS- CoV-2-Related Viruses. mBio 2020; 11Tan Y, Schneider T, Leong M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471829 19. Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Nanomedicine (Lond) 2020; Uskokovic V. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462968 20. Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 2020; Rizzo E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462282 21. Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells. Pharmaceuticals (Basel) 2020; 13Lehene M, Fischer-Fodor E, Scurtu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471171 22. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data. Proteomics 2020:e2000107Gouveia D, Grenga L, Gaillard JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462744 23. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses 2020; 12Younes N, Al-Sadeq DW, Al-Jighefee H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466458

Biomarkers - Genetics (53 articles)

1. Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2. Am J Clin Pathol 2020; Cradic K, Lockhart M, Ozbolt P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462195 2. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 2020; Waltuch T, Gill P, Zinns LE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471782 3. SARS-CoV-2 Presence in seminal fluid: myth or reality. Andrology 2020; Paoli D, Pallotti F, Turriziani O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453494 4. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room. Arch Med Res 2020; Assandri R, Buscarini E, Canetta C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471703 5. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond. Bioanalysis 2020; Kar S, Islam R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32453605 6. Clinical Significance of Blue-Green Neutrophil and Monocyte Cytoplasmic Inclusions in SARS-CoV- 2 Positive Critically Ill Patients. Br. J. Haematol. 2020; Cantu MD, Towne WS, Emmons FN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453859 7. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19). Br. J. Haematol. 2020; Chen W, Li Z, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453877 8. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 2020; Grifoni A, Weiskopf D, Ramirez SI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473127 9. Lymphopenia in COVID-19: Therapeutic Opportunities. Cell Biol. Int. 2020; Fathi N, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458561 10. Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department. Clin Chem Lab Med 2020; Bernasconi L, Oberle M, Gisler V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459191 11. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med 2020; Bohn MK, Lippi G, Horvath A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459192 12. Low levels of total and ionized calcium in blood of COVID-19 patients. Clin Chem Lab Med 2020; Cappellini F, Brivio R, Casati M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459190 13. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med 2020; Tre-Hardy M, Wilmet A, Beukinga I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447328 14. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19. Clin Chim Acta 2020; Saadat M. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454047 15. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). Clin Infect Dis 2020; Tam PCK, Ly KM, Kernich ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472683 16. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling. Clin Infect Dis 2020; Zhang H, Ai JW, Yang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463434 17. The association of low serum albumin level with severe COVID-19: a systematic review and meta- analysis. Crit Care 2020; 24:255Aziz M, Fatima R, Lee-Smith W, Assaly R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456658 18. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients. Crit Care 2020; 24:263Kox M, Frenzel T, Schouten J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456696 19. Duration of SARS-CoV-2 viral RNA in asymptomatic carriers. Crit Care 2020; 24:245Yan X, Han X, Fan Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448332 20. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN). Cureus 2020; 12:e8198Lagziel T, Quiroga L, Ramos M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455090 21. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine- receptor system. Cytokine Growth Factor Rev. 2020; Coperchini F, Chiovato L, Croce L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446778 22. Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis. Diagnostics (Basel) 2020; 10Chen CJ, Hsieh LL, Lin SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32455796 23. Physicochemical properties of SARS-CoV-2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control. Electrophoresis 2020; Scheller C, Krebs F, Minkner R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469436 24. Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States. Emerg Infect Dis 2020; 26Chu VT, Freeman-Ponder B, Lindquist S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470316 25. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerg Microbes Infect 2020:1-14Chen JH, Yip CC, Poon RW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459137 26. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis? Eur J Clin Microbiol Infect Dis 2020; Farfour E, Lesprit P, Visseaux B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462501 27. The amount of cytokine-release defines different shades of Sars-Cov2 infection. Exp. Biol. Med. (Maywood) 2020:1535370220928964Bindoli S, Felicetti M, Sfriso P, Doria A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460624 28. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era. Future Oncol 2020; Veccia A, Kinspergher S, Dipasquale M, Caffo O. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452225 29. Hospital infection and COVID-19: Do not put all your eggs on the "swab" tests. Infect Control Hosp Epidemiol 2020:1-3Chirico F, Nucera G, Magnavita N. http://www.ncbi.nlm.nih.gov/pubmed/? term=32456750 30. A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti- SARS-CoV-2 antibody response. Int J Infect Dis 2020; Lin YC, Cheng CY, Cheng-Pin C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470604 31. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay. J Clin Virol 2020; 128:104448Attwood LO, Francis MJ, Hamblin J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460173 32. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J. Endocrinol. Invest. 2020; Berni A, Malandrino D, Parenti G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451971 33. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection. J Hosp Infect 2020; Sakai J, Tarumoto N, Orihara Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446722 34. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive. J Infect 2020; Borghetti A, Ciccullo A, Paratore M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473233 35. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. J Korean Med Sci 2020; 35:e195Yoon JG, Yoon J, Song JY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449329 36. Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019. J Med Virol 2020; Choe JY, Kim JW, Kwon HH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458479 37. Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam. J Med Virol 2020; Phan LT, Nguyen TV, Huynh LKT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462705 38. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children. J Pediatric Infect Dis Soc 2020; Kam KQ, Yung CF, Maiwald M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32463086 39. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J. Thromb. Thrombolysis 2020; Artifoni M, Danic G, Gautier G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451823 40. The case of Complement activation in COVID-19 multiorgan impact. Kidney Int 2020; Noris M, Benigni A, Remuzzi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461141 41. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J. Intern. Med. 2020; Kang CK, Seong MW, Choi SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460458 42. Immunoinformatic analysis of the SARS-CoV-2 Envelope protein as a strategy to assess cross- protection against COVID-19. Microbes Infect 2020; Tilocca B, Soggiu A, Sanguinetti M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446902 43. Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters. Open Forum Infect Dis 2020; 7:ofaa152Tian S, Liu H, Liao M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457924 44. C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation. Open Forum Infect Dis 2020; 7:ofaa153Wang G, Wu C, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455147 45. Procoagulation, hypercoagulation and fibrinolytic "shut down" detected with ClotPro(R) viscoelastic tests in COVID-19 patients. Orv. Hetil. 2020; 161:899-907Zatroch I, Smudla A, Babik B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453702 46. Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False- Negative Reports. Otolaryngol Head Neck Surg 2020:194599820931793Piras A, Rizzo D, Uzzau S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450754 47. Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan. QJM 2020; Takita M, Matsumura T, Yamamoto K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467977 48. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism. Respir. Med. 2020; 169:106023Garcia-Olive I, Sintes H, Radua J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454268 49. COVID-19 and hypercoagulability in the outpatient setting. Thromb Res 2020; 192:122-123Emert R, Shah P, Zampella JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473495 50. MICROVASCULAR THROMBOSIS: EXPERIMENTAL AND CLINICAL IMPLICATIONS. Transl. Res. 2020; Bray MA, Sartain SA, Gollamudi J, Rumbaut RE. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454092 51. Association of viral load with serum biomakers among COVID-19 cases. Virology 2020; 546:122- 126Shi F, Wu T, Zhu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452410 52. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J. Urol. 2020; Chan VW, Chiu PK, Yee CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462305 53. Antibody tests for COVID-19: What the results tell us. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2020; Horvath K, Semlitsch T, Jeitler K et al.

Children (20 articles)

1. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 2020; Waltuch T, Gill P, Zinns LE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471782 2. Infection control practices in children during COVID-19 pandemic: differences from adults. Am. J. Infect. Control 2020; Devrim I, Bayram N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464297 3. Diagnosis of COVID-19 in children: the story evolves. BMC Med 2020; 18:158Harwood R, Sinha I. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460871 4. Depression and anxiety among adolescents during COVID-19: A cross-sectional study. Brain Behav Immun 2020; Chen F, Zheng D, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464156 5. It's True Even in a Pandemic: Children are Not Merely Little Adults. Clin Infect Dis 2020; Creech CB. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472937 6. Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials. Clin Infect Dis 2020; Raabe VN, Lighter J, Caplan AL, Ratner AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459832 7. Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP). Clin. Transl. Oncol. 2020; Rubio-San-Simon A, Verdu-Amoros J, Hladun R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472454 8. Cutaneous manifestations in COVID-19: a skin rash in a child. Dermatol Ther 2020:e13712Olisova OY, Anpilogova EM, Shnakhova LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472593 9. Compliance and Psychological Impact of Quarantine in Children and Adolescents due to Covid-19 Pandemic. Indian J Pediatr 2020; Saurabh K, Ranjan S. http://www.ncbi.nlm.nih.gov/pubmed/? term=32472347 10. COVID-19 Disease in Children: What Dentists Should Know and Do to Prevent Viral Spread. The Italian Point of View. Int J Environ Res Public Health 2020; 17Ferrazzano GF, Ingenito A, Cantile T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455859 11. Staying home during "COVID-19" decreased fractures, but trauma did not quarantine in one hundred and twelve adults and twenty eight children and the "tsunami of recommendations" could not lockdown twelve elective operations. Int. Orthop. 2020; Hernigou J, Morel X, Callewier A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451655 12. Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic. Ital. J. Pediatr. 2020; 46:68Bignamini E, Cazzato S, Cutrera R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448282 13. Challenges in the Care of Children and Youth With Diabetes in Times of the Corona Pandemic: Personal View of the Situation in a German Clinic. J. Diabetes Sci. Technol. 2020:1932296820930281Ziegler R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468840 14. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol 2020; Labe P, Ly A, Sin C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32455505 15. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues. J Med Virol 2020; Miri SM, Noorbakhsh F, Mohebbi SR, Ghaemi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470174 16. Intubation precautions in a pediatric patient with severe COVID-19. J Pediatr Surg Case Rep 2020; 58:101495Shaw R, Tighe N, Odegard KC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455111 17. Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series. J Pediatric Infect Dis Soc 2020; Chiotos K, Bassiri H, Behrens EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463092 18. Projecting the impact of COVID-19 pandemic on childhood obesity in the U.S.: A microsimulation model. J Sport Health Sci 2020; An R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454174 19. African American children are at higher risk for COVID-19 infection. Pediatr. Allergy Immunol. 2020; Bandi S, Nevid MZ, Mahdavinia M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469426 20. [Coronavirus Covid-19 infection and breastfeeding: an exploratory review]. Rev. Esp. Salud Publica 2020; 94Fernandez-Carrasco FJ, Vazquez-Lara JM, Gonzalez-Mey U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458823

Clinical Features (17 articles) 1. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med 2020; Wilkerson RG, Adler JD, Shah NG, Brown R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471783 2. Cutaneous hyperesthesia: a novel manifestation of COVID-19. Brain Behav Immun 2020; Krajewski PK, Szepietowski JC, Maj J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464157 3. "COVID-Mask": an atypical livedoid manifestation of COVID-19 observed in a northern Italy hospital. Dermatol Ther 2020:e13701Conforti C, Zalaudek I, Giuffrida R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32472566 4. Cutaneous manifestations of COVID-19: A review of the published literature. Dermatol Ther 2020; Elmas OF, Demirbas A, Ozyurt K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458546 5. Cutaneous manifestations in COVID-19: a skin rash in a child. Dermatol Ther 2020:e13712Olisova OY, Anpilogova EM, Shnakhova LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472593 6. Dysphagia in COVID-19 -multilevel damage to the swallowing network? Eur. J. Neurol. 2020; Dziewas R, Warnecke T, Zurcher P, Schefold JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460415 7. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents 2020:106024Lai CC, Ko WC, Lee PI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450197 8. Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro- ischemic lesions. J Am Acad Dermatol 2020; Piccolo V, Bassi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32446827 9. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign". J Am Acad Dermatol 2020; Wambier CG, Vano-Galvan S, McCoy J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446821 10. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J. Emerg. Med. 2020; Dockery DM, Rowe SG, Murphy MA, Krzystolik MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456959 11. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review. J Eur Acad Dermatol Venereol 2020; Docampo-Simon A, Sanchez-Pujol MJ, Juan-Carpena G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452545 12. COVID-19 Presenting with Atypical Sweet's Syndrome. J Eur Acad Dermatol Venereol 2020; Taskin B, Vural S, Altug E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452542 13. The Association between Laryngopharyngeal Reflux and COVID-19 is still not Demonstrated. J Med Virol 2020; Lechien JR, Bartaire E, Bobin F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462666 14. A retrospective study of the initial 25 COVID-19 patients in Luoyang, China. Jpn J Radiol 2020; Duan X, Guo X, Qiang J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458125 15. Oncologic patient with COVID-19 discovered incidentally by PET/CT examination: (A COVID-19- pandemia orvosszakmai kerdesei). Orv. Hetil. 2020; 161:971-976Czibor S, Kristof E, Kecskes K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453695 16. Chilblains-like lesions and COVID-19. Pediatr. Dermatol. 2020; Joob B, Wiwanitkit V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453902 17. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:E018Jiang SW, Gao H, Wu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455515

CNS (29 articles)

1. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19. ACS Chem Neurosci 2020; Baig AM, Sanders EC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469504 2. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020; Reichard RR, Kashani KB, Boire NA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449057 3. Olfactory dysfunction in COVID-19, a review of the evidence and implications for pandemic management. Acta Otorrinolaringol. Esp. 2020; Lop Gros J, Iglesias Coma M, Gonzalez Farre M, Serra Pujadas C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466862 4. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann Intern Med 2020; Lechien JR, Chiesa-Estomba CM, Hans S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449883 5. Cutaneous hyperesthesia: a novel manifestation of COVID-19. Brain Behav Immun 2020; Krajewski PK, Szepietowski JC, Maj J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464157 6. Anosmia in COVID-19 patients. Clin Microbiol Infect 2020; Hornuss D, Lange B, Schroter N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447049 7. A Review of Neurological Complications of COVID-19. Cureus 2020; 12:e8192Sheraton M, Deo N, Kashyap R, Surani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455089 8. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study. Ear Nose Throat J 2020:145561320929169Lechien JR, Cabaraux P, Chiesa-Estomba CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469246 9. New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects. Eur Arch Otorhinolaryngol 2020; Boscolo-Rizzo P, Borsetto D, Spinato G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449021 10. The role of self-reported smell and taste disorders in suspected COVID19. Eur Arch Otorhinolaryngol 2020; Printza A, Constantinidis J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447496 11. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur. J. Neurol. 2020; de Freitas Ferreira ACA, Romao TT, Y SIM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449248 12. Dysphagia in COVID-19 -multilevel damage to the swallowing network? Eur. J. Neurol. 2020; Dziewas R, Warnecke T, Zurcher P, Schefold JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460415 13. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp. Mol. Pathol. 2020:104474Lavi E, Cong L. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454103 14. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. Gen. Hosp. Psychiatry 2020; 65:47-53Beach SR, Praschan NC, Hogan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470824 15. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19. J. Cardiovasc. Transl. Res. 2020; Fudim M, Qadri YJ, Ghadimi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458400 16. SARS-CoV-2 Infection Leads to Neurological Dysfunction. J. Neuroimmune Pharmacol. 2020; Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447746 17. Neurological manifestations of COVID-19: a review of what we know so far. J. Neurol. 2020; Gklinos P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458197 18. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J. Neurol. 2020; Zhou Z, Kang H, Li S, Zhao X. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458193 19. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020; 414:116923Jain R, Young M, Dogra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447193 20. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci 2020; 414:116884Roman GC, Spencer PS, Reis J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464367 21. COVID-19 and the nervous system. J. Neurovirol. 2020; Berger JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447630 22. Effects of COVID-19 on Parkinson's disease clinical features: a community-based case-control study. Mov Disord 2020; Cilia R, Bonvegna S, Straccia G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449528 23. Olfactory dysfunction in recovered COVID-19 patients. Mov Disord 2020; Li J, Long X, Zhu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468632 24. Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case. Mult Scler Relat Disord 2020; 43:102216Afshar H, Yassin Z, Kalantari S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464585 25. Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Mult Scler Relat Disord 2020; 43:102222Ghajarzadeh M, Mirmosayyeb O, Barzegar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464586 26. Brainstem involvement and respiratory failure in COVID-19. Neurol Sci 2020; Manganelli F, Vargas M, Iovino A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472516 27. The involvement of the central nervous system in patients with COVID-19. Rev. Neurosci. 2020; Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463395 28. Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris. Stroke 2020:Strokeaha120030574Escalard S, Maier B, Redjem H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466736 29. Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins Experience. World Neurosurg 2020; Khalafallah AM, Jimenez AE, Lee RP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32461176

Complications (57 articles)

1. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDS 2020; Ridgway JP, Farley B, Benoit JL et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469614 2. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 2020; Waltuch T, Gill P, Zinns LE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471782 3. Early COVID-19 infection after lung transplantation. Am J Transplant 2020; Keller BC, Le A, Sobhanie M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471004 4. It is currently unknown whether SARS-CoV-2 is viable in semen or whether COVID-19 damages sperm. Andrology 2020; Perry MJ, Arrington S, Neumann LM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471002 5. Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients? Br. J. Haematol. 2020; Angileri F, Legare S, Marino Gammazza A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453861 6. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19). Br. J. Haematol. 2020; Chen W, Li Z, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453877 7. Anti-NMDA Receptor Encephalitis in a Psychiatric Covid-19 Patient: a Case Report. Brain Behav Immun 2020; Panariello A, Bassetti R, Radice A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454137 8. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 2020; 22:55Vuagnat P, Frelaut M, Ramtohul T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32460829 9. Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process. Cancer 2020; Perni S, Milligan MG, Saraf A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32463478 10. Need for Objective Assessment of Volume Status in Critically Ill Patients with COVID-19: The Tri- POCUS Approach. Cardiorenal Med. 2020:1-8Koratala A, Ronco C, Kazory A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460302 11. Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review. Clin Rheumatol 2020; Dai J, Xiong Y, Li H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451729 12. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients. Crit Care 2020; 24:263Kox M, Frenzel T, Schouten J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456696 13. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN). Cureus 2020; 12:e8198Lagziel T, Quiroga L, Ramos M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455090 14. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine- receptor system. Cytokine Growth Factor Rev. 2020; Coperchini F, Chiovato L, Croce L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446778 15. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Dermatol Ther (Heidelb) 2020; Brownstone ND, Thibodeaux QG, Reddy VD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468230 16. Jointly providing for severe COVID-19 cases: Interview with a hospital pharmacist. Deutsche Apotheker Zeitung 2020; 60Dedy J. 17. COVID-19 Triage: Who is an inpatient? The Essen triage model. Deutsche medizinische Wochenschrift (1946) 2020; Fistera D, Risse J, Manegold R et al. 18. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med 2020; Bengoechea JA, Bamford CGG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453917 19. Informing Emergency Care for all patients: The Registry for Emergency Care (REC) Project Protocol. Emerg. Med. Australas. 2020; O'Reilly GM, Mitchell RD, Mitra B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462732 20. Indications and timing for tracheostomy in patients with SARS CoV2-related. Eur Arch Otorhinolaryngol 2020; Ferri E, Boscolo Nata F, Pedruzzi B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32458121 21. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant. Eur J Heart Fail 2020; Benzakoun J, Hmeydia G, Delabarde T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463538 22. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur. J. Neurol. 2020; de Freitas Ferreira ACA, Romao TT, Y SIM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449248 23. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp. Mol. Pathol. 2020:104474Lavi E, Cong L. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454103 24. Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? Future Oncol 2020; Hays P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456461 25. Does SARS-CoV-2 infection cause chronic neurological complications? Geroscience 2020; Hascup ER, Hascup KN. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451846 26. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic. Indian J Pediatr 2020; Rauf A, Vijayan A, John ST et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462354 27. Bowel perforation in a Covid-19 patient: case report. Int. J. Colorectal Dis. 2020; De Nardi P, Parolini DC, Ripa M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458395 28. Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient. Int J Infect Dis 2020; Andrea V, Gianluca F, Rodolfo P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447121 29. Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China. Int J Infect Dis 2020; Ma S, Lai X, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470606 30. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 2020; Jain V, Yuan JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451563 31. Covid-19 induced superimposed bacterial infection. J Biomol Struct Dyn 2020:1-10Hendaus MA, Jomha FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448041 32. The COVID-19 Infection in Italy: A Statistical Study of an Abnormally Severe Disease. J Clin Med 2020; 9De Natale G, Ricciardi V, De Luca G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455807 33. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes. J Clin Virol 2020; 128:104436Wee LE, Ko KKK, Ho WQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447256 34. Late onset of acral necrosis after SARS-CoV-2 infection resolution. J Eur Acad Dermatol Venereol 2020; Balestri R, Termine S, Rech G, Girardelli CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455499 35. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol 2020; Labe P, Ly A, Sin C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32455505 36. A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue. J Eur Acad Dermatol Venereol 2020; Torres-Navarro I, Abril-Perez C, Roca-Gines J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32455478 37. The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome. J Med Virol 2020; Li T, Cheng GS, Pipavath S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470156 38. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis? J Med Virol 2020; Liu M, Dai C, Lv X, Li B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470212 39. Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City. J Med Virol 2020; Suwanwongse K, Shabarek N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462663 40. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020; 414:116923Jain R, Young M, Dogra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447193 41. Intubation precautions in a pediatric patient with severe COVID-19. J Pediatr Surg Case Rep 2020; 58:101495Shaw R, Tighe N, Odegard KC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455111 42. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J. Thromb. Thrombolysis 2020; Artifoni M, Danic G, Gautier G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451823 43. Management of Upper Airway Bleeding in COVID-19 Patients on Extracorporeal Membrane Oxygenation. Laryngoscope 2020; LoSavio PS, Patel T, Urban MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470179 44. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 2020; 255:117839Renu K, Prasanna PL, Valsala Gopalakrishnan A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32450165 45. Brainstem involvement and respiratory failure in COVID-19. Neurol Sci 2020; Manganelli F, Vargas M, Iovino A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472516 46. Procoagulation, hypercoagulation and fibrinolytic "shut down" detected with ClotPro(R) viscoelastic tests in COVID-19 patients. Orv. Hetil. 2020; 161:899-907Zatroch I, Smudla A, Babik B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453702 47. Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19. Otolaryngol Head Neck Surg 2020:194599820931801Riestra-Ayora J, Yanes-Diaz J, Penuelas O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450761 48. COVID-19: Komorbiditäten prädisponieren für schweren Verlauf. Pneumologie 2020; 74:257Franke K. 49. Prone positioning to improve oxygenation and relieve respiratory symptoms in awake, spontaneously breathing non-intubated patients with COVID-19 pneumonia. Respir Med Case Rep 2020; 30:101096Sztajnbok J, Maselli-Schoueri JH, Cunha de Resende Brasil LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455107 50. COVID-19 and hypercoagulability in the outpatient setting. Thromb Res 2020; 192:122-123Emert R, Shah P, Zampella JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473495 51. MICROVASCULAR THROMBOSIS: EXPERIMENTAL AND CLINICAL IMPLICATIONS. Transl. Res. 2020; Bray MA, Sartain SA, Gollamudi J, Rumbaut RE. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454092 52. COVID-19 in an HIV-positive Kidney Transplant Recipient. Transpl Infect Dis 2020:e13338Kumar RN, Tanna SD, Shetty AA, Stosor V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453483 53. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis 2020:e13334Lauterio A, Valsecchi M, Santambrogio S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449235 54. Covid-19 in solid organ transplant recipients: A single center experience. Transpl Int 2020; Hoek RAS, Manintveld OC, Betjes MGH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460390 55. Prevention of thrombosis in pregnant women with suspected SARS-CoV-2 infection: clinical management algorithm. Ultrasound Obstet Gynecol 2020; Lou-Mercade AC, Gavin O, Oros D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449242 56. Liver injury in COVID-19: The current evidence. United European Gastroenterol J 2020; 8:509- 519Alqahtani SA, Schattenberg JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450787 57. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy. Vasa 2020:1-5Galastri FL, Valle LGM, Affonso BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462990

Cured – Recovered (5 articles)

1. The COVID-19 Rehabilitation Pandemic. Age Ageing 2020; De Biase S, Cook L, Skelton DA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470131 2. COVID-19: The road to recovery. Am. J. Surg. 2020; Diaz A, Rahmanian A, Pawlik TM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446466 3. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med 2020; Ahmed H, Patel K, Greenwood DC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449782 4. Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Mult Scler Relat Disord 2020; 43:102222Ghajarzadeh M, Mirmosayyeb O, Barzegar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464586 5. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res 2020; 21:125Liu D, Zhang W, Pan F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448391

Cardiovascular disease (34 articles)

1. An update on ACE2 amplification and its therapeutic potential. Acta Physiol. (Oxf.) 2020:e13513Marquez A, Wysocki J, Pandit J, Batlle D. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469114 2. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG. Aging Male 2020:1- 4Ozturk F, Karaduman M, Coldur R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449420 3. Management of heart transplant candidates in the time of COVID-19 pandemic: looking for answers. Am J Transplant 2020; Pascale R, Trapani F, Potena L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470181 4. Surveillance for COVID-19 in cardiac inpatients: containing COVID-19 in a specialised cardiac centre. Can J Cardiol 2020; Wee LE, Wen R, Jean Sim XY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473301 5. STEMI during the COVID-19 Pandemic - An Evaluation of Incidence. Cardiovasc. Pathol. 2020; 48:107232Zitelny E, Newman N, Zhao D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454398 6. Decreased myocardial infarction admissions during COVID times: what can we learn? Cardiovasc Res 2020; Niccoli G, Luescher TF, Crea F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463078 7. Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic. Cardiovasc. Revasc. Med. 2020; Yerasi C, Case BC, Forrestal BJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471712 8. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study. Circulation 2020; Szekely Y, Lichter Y, Taieb P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469253 9. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol 2020; Bohm M, Frey N, Giannitsis E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462267 10. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia. Crit Care 2020; 24:257Hu L, Gong L, Jiang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456695 11. The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population. Curr. Oncol. Rep. 2020; 22:60Asokan I, Rabadia SV, Yang EH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462289 12. Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers. Deutsche medizinische Wochenschrift (1946) 2020; 145:682-686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F. 13. Rapid guide to the management of cardiac patients during the COVID-19 pandemic in Egypt: "a position statement of the Egyptian Society of Cardiology". Egypt Heart J 2020; 72:30Shaheen S, Awwad O, Shokry K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462497 14. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020. Emerg Infect Dis 2020; 26Zayet S, Klopfenstein T, Kovacs R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453685 15. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic. A survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes 2020; Pessoa-Amorim G, Camm CF, Gajendragadkar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467968 16. Heart failure management during COVID-19 outbreak in Italy. Telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail 2020; Salzano A, D'Assante R, Stagnaro FM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463534 17. Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020; Zhang Y, Stewart Coats AJ, Zheng Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463543 18. Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia during the COVID-19 Pandemic: A Living Document. Heart Lung Circ. 2020; Kumar S, Haqqani H, Wynn G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451232 19. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic. Indian J Pediatr 2020; Rauf A, Vijayan A, John ST et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462354 20. ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19. J Allergy Clin Immunol 2020; Bradding P, Richardson M, Hinks TSC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450087 21. Declines in Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic: A Multicenter Tertiary Care Experience. J Am Coll Cardiol 2020; Bhatt AS, Moscone A, McElrath EE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470516 22. Transcatheter Aortic Valve Replacement in the Coronavirus Disease 2019 (COVID-19) Era. J Am Heart Assoc 2020:e017121Mentias A, Jneid H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452247 23. Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring. J Am Heart Assoc 2020:e017144Ramireddy A, Chugh H, Reinier K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463348 24. COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? J Intern Med 2020; Aleksova A, Ferro F, Gagno G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459372 25. Rhythm blues in the time of coronavirus disease 2019 (COVID-19): how the cardiac electrophysiologist adapts to a viral pandemic in Singapore. J. Interv. Card. Electrophysiol. 2020; Chia PL, Tan K, Tan LW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458182 26. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure". mBio 2020; 11Fedson DS, Opal SM, Rordam OM. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471831 27. Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19. Med. Hypotheses 2020; 143:109859Ponti G, Ruini C, Tomasi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464494 28. Ischaemic stroke and SARS-CoV-2 infection: A causal or incidental association? Neurologia 2020; Barrios-Lopez JM, Rego-Garcia I, Munoz Martinez C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448674 29. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr. Metab. Cardiovasc. Dis. 2020; Li M, Dong Y, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32456948 30. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism. Respir. Med. 2020; 169:106023Garcia-Olive I, Sintes H, Radua J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454268 31. [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]. Semergen 2020; Pallares Carratala V, Gorriz-Zambrano C, Morillas Arino C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448633 32. Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris. Stroke 2020:Strokeaha120030574Escalard S, Maier B, Redjem H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466736 33. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China. Stroke 2020:Strokeaha120030365Qin C, Zhou L, Hu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32466735 34. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy. Vasa 2020:1-5Galastri FL, Valle LGM, Affonso BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462990

Diagnosis (4 articles)

1. Diagnosis of COVID-19 in children: the story evolves. BMC Med 2020; 18:158Harwood R, Sinha I. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460871 2. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study. Ear Nose Throat J 2020:145561320929169Lechien JR, Cabaraux P, Chiesa-Estomba CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469246 3. The outlook for diagnostic purposes of the 2019-novel coronavirus disease. J. Cell. Physiol. 2020; Tahmasebi S, Khosh E, Esmaeilzadeh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452050 4. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review. J Med Syst 2020; 44:122Albahri AS, Hamid RA, Alwan JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451808

DM-MS-Obesity (27 articles)

1. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19. Aging (Albany NY) 2020; 12Menendez JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463794 2. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab 2020; Korakas E, Ikonomidis I, Kousathana F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459524 3. A new diagnostic strategy for gestational diabetes during the COVID-19 pandemic for the Japanese population. Diabetes Metab Res Rev 2020:e3351Kasuga Y, Saisho Y, Ikenoue S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453497 4. SARS-CoV-2 and Diabetes: New Challenges for the Disease. Diabetes Res Clin Pract 2020:108228Cristelo C, Azevedo C, Moreira Marques J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32446801 5. Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study. Diabetes Res Clin Pract 2020:108227Zhang Y, Cui Y, Shen M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446795 6. Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends. Diabetes Ther. 2020; Bossi AC, Forloni F, Colombelli PL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447736 7. Diabetes and pregnancy—update 2020. Diabetologe 2020; Kleinwechter H. 8. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020; Cariou B, Hadjadj S, Wargny M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472191 9. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis. Int J Environ Res Public Health 2020; 17Mirabelli M, Chiefari E, Puccio L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32456064 10. COVID-19 and diabetes: Is there enough evidence? J. Clin. Hypertens. (Greenwich) 2020; Tadic M, Cuspidi C, Sala C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472662 11. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?". J. Diabetes 2020; Pal R, Banerjee M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459882 12. The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support. J. Diabetes Sci. Technol. 2020:1932296820929721Arsand E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460550 13. Relative Limited Impact of COVID-19 on Diabetes: A Personal View. J. Diabetes Sci. Technol. 2020:1932296820930270de Galan BE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468834 14. The Time of Uncertainty in Poland. J. Diabetes Sci. Technol. 2020:1932296820931485Dzida GJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460551 15. Personal Experience With COVID-19 and Community Screening of Diabetic Retinopathy in Iran. J. Diabetes Sci. Technol. 2020:1932296820930045Jamali S, Ashrafi E, Mohammadi SF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460540 16. Benefits of Technology in the Age of COVID-19 and Diabetes. . .Mobile Phones From a Rwanda Perspective. J. Diabetes Sci. Technol. 2020:1932296820930032Krisiunas E, Sibomana L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460536 17. Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience). J. Diabetes Sci. Technol. 2020:1932296820930031Mankovsky B. http://www.ncbi.nlm.nih.gov/pubmed/? term=32468843 18. Personal Experiences With COVID-19 and Diabetes Technology: All for Technology Yet Not Technology for All. J. Diabetes Sci. Technol. 2020:1932296820930005Monaghan M, Marks B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460543 19. Diabetes and Technology in the Covid-19 Pandemic Crisis. J. Diabetes Sci. Technol. 2020:1932296820929385Spanakis EK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460544 20. Would You Believe? A Virus Changes Diabetes Care. J. Diabetes Sci. Technol. 2020:1932296820929381Tack CCJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460553 21. COVID-19, Type 1 Diabetes Clinical Practice, Research, and Remote Medical Care: A View From the Land Down-Under. J. Diabetes Sci. Technol. 2020:1932296820929708Venkatesh N, Paldus B, Lee MH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468858 22. Challenges in the Care of Children and Youth With Diabetes in Times of the Corona Pandemic: Personal View of the Situation in a German Clinic. J. Diabetes Sci. Technol. 2020:1932296820930281Ziegler R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468840 23. Self-quarantine and weight gain related risk factors during the COVID-19 pandemic. Obes. Res. Clin. Pract. 2020; Zachary Z, Brianna F, Brianna L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460966 24. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return? Obesity (Silver Spring) 2020; Briand-Mesange F, Trudel S, Salles J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463562 25. Obesity and COVID-19: an Italian snapshot. Obesity (Silver Spring) 2020; Busetto L, Bettini S, Fabris R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463545 26. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City. Obesity (Silver Spring) 2020; Hajifathalian K, Kumar S, Newberry C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470210 27. Diabetes and COVID-19. Therapie 2020; Bouhanick B, Cracowski JL, Faillie JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471607

Education and training and science (21 articles)

1. In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs. AAPS PharmSciTech 2020; 21:153Gurvich VJ, Hussain AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449007 2. The Impact of COVID-19 on Plastic Surgery Residency Training. Aesthetic Plast. Surg. 2020; Zingaretti N, Contessi Negrini F, Tel A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458042 3. Redefining undergraduate nurse teaching during the coronavirus pandemic: use of digital technologies. Br J Nurs 2020; 29:566-569Leigh J, Vasilica C, Dron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463742 4. COVID-19 Implications on Clinical Clerkships and the Residency Application Process for Medical Students. Cureus 2020; 12:e7800Akers A, Blough C, Iyer MS. http://www.ncbi.nlm.nih.gov/pubmed/? term=32461867 5. Provision of e-learning programmes to replace undergraduate medical students' clinical general practice attachments during COVID-19 stand-down. Educ. Prim. Care 2020:1-8Roskvist R, Eggleton K, Goodyear-Smith F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469632 6. The future of cancer research after COVID-19 pandemic: recession? Future Oncol 2020; Kourie HR, Eid R, Haddad F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469283 7. Psychological impact of COVID-19 on ophthalmologists-in-training and practising ophthalmologists in India. Indian J Ophthalmol 2020; 68:994-998Khanna RC, Honavar SG, Metla AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461412 8. Research Progress of Coronavirus Based on Bibliometric Analysis. Int J Environ Res Public Health 2020; 17Zhai F, Zhai Y, Cong C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466477 9. Recommendations for Medical Student Preparedness and Equity for Dermatology Residency Applications During the COVID-19 Pandemic. J Am Acad Dermatol 2020; Stewart CR, Chernoff KA, Wildman HF, Lipner SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450096 10. The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials. J Am Coll Cardiol 2020; Bagiella E, Bhatt DL, Gaudino M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470514 11. Racism and the Political Economy of COVID-19: Will We Continue to Resurrect the Past? J. Health Polit. Policy Law 2020; Bailey ZD, Moon JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464657 12. Effect of COVID-19 on Urology Residency Training: A Nationwide Survey of Program Directors by the Society of Academic Urologists. J Urol 2020:101097ju0000000000001155Rosen GH, Murray KS, Greene KL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463716 13. COVID-19: Challenges and Lessons Learned from Early Career Investigators. J Womens Health (Larchmt) 2020; Denfeld Q, Erickson E, Valent A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469620 14. A letter to the editor: the impact of COVID-19 on intercalating and non-clinical medical students in the UK. Med. Educ. Online 2020; 25:1771245Abedi M, Abedi D. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449490 15. What COVID-19 outbreak in Iran teaches us about virtual medical education. Med. Educ. Online 2020; 25:1770567Aghakhani K, Shalbafan M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449487 16. Preparedness of medical education in China: Lessons from the COVID-19 outbreak. Med. Teach. 2020:1-4Yang DY, Cheng SY, Wang SZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468890 17. Teaching at the paramedics school of the City of Munich during the COVID-19 pandemic. Notfall und Rettungsmedizin 2020; Frieß C, Bayerl T. 18. Increasing global awareness of timely COVID-19 healthcare guidelines through FPV training tutorials: Portable public health crises teaching method. Nurse Educ. Today 2020; 91:104479Ros M, Neuwirth LS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473497 19. "The storm has arrived": the impact of SARS-CoV-2 on medical students. Perspect Med Educ 2020; Klasen JM, Vithyapathy A, Zante B, Burm S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458382 20. COVID-19 and Neurosurgical Education in Africa: Making lemonade from lemons. World Neurosurg 2020; Kanmounye US, Esene IN. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446982 21. Letter: Changes to neurosurgery resident education following onset of the COVID-19 pandemic. World Neurosurg 2020; Pennington Z, Lubelski D, Khalafallah A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3245031

Elderly (8 articles)

1. The preventive strategy for pandemics in the elderly is to collect in advance samples & data to counteract chronic inflammation (inflammaging). Ageing Res Rev 2020:101091Fuellen G, Liesenfeld O, Kowald A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454090 2. Why does COVID-19 disproportionately affect older people? Aging (Albany NY) 2020; 12Mueller AL, McNamara MS, Sinclair DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470948 3. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin. Exp. Res. 2020; Palmer K, Monaco A, Kivipelto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458356 4. Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy. Int J Infect Dis 2020; Jang S, Rhee JY. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470602 5. Reaching older adults during the COVID-19 pandemic through social networks and Social Security Schemes in Ghana: Lessons for considerations. J Gerontol Soc Work 2020:1-3Arthur-Holmes F, Agyemang-Duah W. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449640 6. Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond. J. Natl. Cancer Inst. 2020; Freedman RA, Sedrak MS, Bellon JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449757 7. Recommendations for the Treatment of Elderly Patients with COVID-19 from the Taskforce for Gerontopneumology. Pneumologie (Stuttgart, Germany) 2020; Stieglitz S, Frohnhofen H, Netzer N et al. 8. Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Rev Esp Cardiol (Engl Ed) 2020; Bonanad C, Garcia-Blas S, Tarazona-Santabalbina FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446793

Epidemiology (58 articles)

1. SARS-CoV-2 Virulence: Interplay of Floating Virus-Laden Particles, Climate, and Humans. Adv Biosyst 2020:e2000105Hosseini V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449297 2. A novel COVID-19 based truck driver syndemic? Implications for public health, safety, and vital supply chains. Am. J. Ind. Med. 2020; Lemke MK, Apostolopoulos Y, Sonmez S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452556 3. The effect of state-level stay-at-home orders on COVID-19 infection rates. Am. J. Infect. Control 2020; Castillo RC, Staguhn ED, Weston-Farber E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461066 4. Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic. Arch Med Res 2020; Perez Perez GI, Talebi Bezmin Abadi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446538 5. A Statistical Modeling of the Course of COVID-19 (SARS-CoV-2) Outbreak: A Comparative Analysis. Asia Pac. J. Public Health 2020:1010539520928180Ankarali H, Ankaralli S, Caskurlu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450712 6. Predicting intervention effect for COVID-19 in Japan: state space modeling approach. Biosci Trends 2020; Kobayashi G, Sugasawa S, Tamae H, Ozu T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461511 7. Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach. BMC Med 2020; 18:157Aleta A, Moreno Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456689 8. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med 2020; 18:160Niedzwiedz CL, O'Donnell CA, Jani BD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466757 9. Epidemiological models are important tools for guiding COVID-19 interventions. BMC Med 2020; 18:152Thompson RN. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448247 10. Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies. Clin Infect Dis 2020; Huff HV, Singh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463076 11. A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings. Clin Infect Dis 2020; Temime L, Gustin MP, Duval A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473007 12. Coronavirus (SARS-CoV-2) - Outbreak in North Rhine-Westphalia (District of Heinsberg) - First diagnosis of a COVID-19 manifestation in a couple. Deutsche medizinische Wochenschrift (1946) 2020; 145:665-669Laufs J, Elsbernd H, Hölzl F, Winter KD. 13. Epidemiology and control of COVID-19. Deutsche medizinische Wochenschrift (1946) 2020; 145:670- 674Müller O, Neuhann F, Razum O. 14. When predictions are used to allocate scarce health care resources: three considerations for models in the era of Covid-19. Diagn Progn Res 2020; 4:11Kent DM, Paulus JK, Sharp RR, Hajizadeh N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455168 15. Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States. Emerg Infect Dis 2020; 26Chu VT, Freeman-Ponder B, Lindquist S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470316 16. Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China. Emerg Infect Dis 2020; 26Zhang W, Cheng W, Luo L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453686 17. Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa. Emerg Microbes Infect 2020; 9:1077-1079Jaja IF, Anyanwu MU, Iwu Jaja CJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459603 18. COVID-19 pandemic - An African perspective. Emerg Microbes Infect 2020:1-28Lone SA, Ahmad A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458760 19. Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios. Front Med 2020; Xu C, Dong Y, Yu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468343 20. [Health statistics and invisibility by sex and gender during the COVID-19 epidemic]. Gac. Sanit. 2020; Ruiz Cantero MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446594 21. Deaths in nine regions of Italy in February/March 2020: "Mortality Excess Loupe" for SARS-CoV- 2/COVID-19-Epidemiology in Germany. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2020; Morfeld P, Erren TC. 22. Mechanistic inferences from clinical reports of SARS-CoV-2. Infect Dis (Lond) 2020:1-11Jenkins MM, McCaw TR, Goepfert PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459123 23. The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway. Int J Environ Res Public Health 2020; 17Capalbo C, Aceti A, Simmaco M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471066 24. Prioritizing and Analyzing the Role of Climate and Urban Parameters in the Confirmed Cases of COVID-19 Based on Artificial Intelligence Applications. Int J Environ Res Public Health 2020; 17Shaffiee Haghshenas S, Pirouz B, Shaffiee Haghshenas S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32466199 25. Italian Public Health Response to the COVID-19 Pandemic: Case Report from the Field, Insights and Challenges for the Department of Prevention. Int J Environ Res Public Health 2020; 17Torri E, Sbrogio LG, Rosa ED et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456072 26. Evaluating Transmission Heterogeneity and Super-Spreading Event of COVID-19 in a Metropolis of China. Int J Environ Res Public Health 2020; 17Zhang Y, Li Y, Wang L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456346 27. Is Nigeria prepared and ready to respond to the COVID-19 pandemic in its conflict-affected northeastern states? Int J Equity Health 2020; 19:77Tijjani SJ, Ma L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460766 28. COVID-19: how to make between-country comparisons. Int J Infect Dis 2020; Middelburg RA, Rosendaal FR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470605 29. COVID-19 Pandemic: Marked Global Disparities in Fatalities According to Geographic Location and Universal Health Care. Int J MCH AIDS 2020; 9:213-216Dongarwar D, Salihu HM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461818 30. Constructing Co-occurrence Network Embeddings to Assist Association Extraction for COVID-19 and Other Coronavirus Infectious Diseases. J Am Med Inform Assoc 2020; Oniani D, Jiang G, Liu H, Shen F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458963 31. Coronavirus (COVID-19): Let's Prevent Not Panic. J. Ayub Med. Coll. Abbottabad 2020; 32:141- 144Mukhtar F, Mukhtar N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468775 32. Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics. J Clin Med 2020; 9Kaden R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466577 33. Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway. J. Diabetes Sci. Technol. 2020:1932296820929371Birkeland KI. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456527 34. An introduction to economic studies, health emergencies, and COVID-19. J Evid Based Med 2020; 13:161-167Clarke L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470229 35. Equitable Pandemic Preparedness and Rapid Response: Lessons from COVID-19 for Pandemic Health Equity. J. Health Polit. Policy Law 2020; Alberti PM, Lantz PM, Wilkins CH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464654 36. Understanding the Anemic Global Response to COVID-19. J. Health Polit. Policy Law 2020; Busby JW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464668 37. Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan and Singapore. J Hosp Infect 2020; On Kwok K, Hin Chan HH, Huang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446721 38. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020; Lansbury L, Lim B, Baskaran V, Lim WS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473235 39. Imported and locally transmitted mild SARS-CoV-2 pneumonia cases in Japan. J Infect Chemother 2020; Tochitani K, Iwamoto N, Motobayashi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471794 40. Response to Malkovsky. J Infect Dis 2020; Zeng QL, Ji F, Zhang JY. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473012 41. Racial Disparities in COVID-19 Deaths Reveal Harsh Truths About Structural Inequality in America. J Intern Med 2020; Anyane-Yeboa A, Sato T, Sakuraba A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32452046 42. Using Reports of Symptoms and Diagnoses on Social Media to Predict COVID-19 Case Counts in Mainland China: Observational Infoveillance Study. J Med Internet Res 2020; 22:e19421Shen C, Chen A, Luo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452804 43. Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis. J Med Virol 2020; He W, Yi GY, Zhu Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470164 44. The COVID-19 infection: lessons from the Italian experience. J. Public Health Policy 2020; Romagnani P, Gnone G, Guzzi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472024 45. Projecting the impact of COVID-19 pandemic on childhood obesity in the U.S.: A microsimulation model. J Sport Health Sci 2020; An R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454174 46. Familial cluster of SARS-CoV-2 infection associated with a railway journey. J Travel Med 2020; Qiu S, Liu H, Li P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463446 47. Pandemic COVID-19 Joins History's Pandemic Legion. mBio 2020; 11Morens DM, Daszak P, Markel H, Taubenberger JK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471830 48. Together against COVID-19. MMW-Fortschritte der Medizin 2020; 162:73Red. 49. Caution is needed on the effect of altitude on the pathogenesis of SAR-CoV-2 virus. Respir. Physiol. Neurobiol. 2020:103464Burtscher J, Burtscher M, Millet GP. http://www.ncbi.nlm.nih.gov/pubmed/? term=32447057 50. First detection of SARS-CoV-2 in untreated wastewaters in Italy. Sci Total Environ 2020; 736:139652La Rosa G, Iaconelli M, Mancini P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464333 51. Asymmetric nexus between temperature and COVID-19 in the top ten affected provinces of China: A current application of quantile-on-quantile approach. Sci Total Environ 2020; 736:139115Shahzad F, Shahzad U, Fareed Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470687 52. The COVID-19 Pandemic in Japan. Surg. Today 2020; Watanabe M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462468 53. COVID-19 Waves: Importance of Accumulative Mortality per Million Inhabitants. Tohoku J. Exp. Med. 2020; 251:47-49Delgado CA, Shimabuku RL, Chiroque-Solano PM. http://www.ncbi.nlm.nih.gov/pubmed/? term=32461502 54. Estimation of the Serial Interval and Basic Reproduction Number of COVID-19 in Qom, Iran, and Three Other Countries: A Data-Driven Analysis in the Early Phase of the Outbreak. Transbound Emerg Dis 2020; Aghaali M, Kolifarhood G, Nikbakht R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473049 55. Estimating the serial interval of the novel coronavirus disease (COVID-19) based on the public surveillance data in Shenzhen, China from January 19 to February 22, 2020. Transbound Emerg Dis 2020; Wang K, Zhao S, Liao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452648 56. What We Need to Consider During and After the SARS-CoV-2 Pandemic. Vector Borne Zoonotic Dis. 2020; Valdivia-Granda WA, Richt JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469633 57. [Epidemiological characteristics of infection in COVID-19 close contacts in Ningbo city]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:667-671Chen Y, Wang AH, Yi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447904 58. [Risk assessment of global COVID-19 imported cases into China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:E070Shen SP, Wei YY, Zhao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455514 Gastro-enterology-hepatology (15 articles)

1. Plans to Reactivate Gastroenterology Practices Following the COVID-19 Pandemic: A Survey of North American Centers. Clin Gastroenterol Hepatol 2020; Kushnir VM, Berzin TM, Elmunzer BJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447019 2. Successful Conservative Management of Acute Appendicitis in a Coronavirus Disease 2019 (COVID- 19) Patient. Cureus 2020; 12:e7834Suwanwongse K, Shabarek N. http://www.ncbi.nlm.nih.gov/pubmed/? term=32467809 3. Clinical Insights into the Gastrointestinal Manifestations of COVID-19. Dig. Dis. Sci. 2020; Kopel J, Perisetti A, Gajendran M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447742 4. Clinical Questions and Answers on Gastrointestinal Endoscopy during the Novel COVID-19 Pandemic. Dig Endosc 2020; Furuta T, Irisawa A, Matsumoto T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470171 5. Control measures to prevent Coronavirus disease 2019 COVID-19pandemic in endoscopy centers: a multi-centre study. Dig Endosc 2020; Huang Q, Liu G, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473036 6. Initial Gastrointestinal Manifestations in Patients with SARS-CoV-2 in 112 patients from Veracruz (Southeastern Mexico). Gastroenterology 2020; Remes-Troche JM, Ramos-de-la-Medina A, Manriquez- Reyes M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446696 7. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations. Hepatol Int 2020; Lau G, Sharma M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447721 8. IBD in the Times of COVID-19. Inflamm. Bowel Dis. 2020; Hernandez Benabe S, Langshaw AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448895 9. An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise. J Hepatol 2020; Chew CA, Iyer SG, Chieh Kow AW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454041 10. SARS-CoV-2 related liver impairment - perception may not be the reality. J Hepatol 2020; Philips CA, Ahamed R, Augustine P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454042 11. Features of Enteric Disease from Human Coronaviruses: Implications for COVID-19. J Med Virol 2020; Cimolai N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462689 12. Recommendations for Performing Bronchoscopy in Times of the COVID-19 Pandemic. Pneumologie 2020; 74:260-262Darwiche K, Ross B, Gesierich W et al. 13. Knowledge of Latin American gastroenterologists and endoscopists regarding SARS-CoV-2 infection. Rev. Gastroenterol. Mex. 2020; Ruiz-Manriquez J, Leon-Lara X, Campos-Murguia A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466830 14. The risk of COVID-19 transmission by laparoscopic smoke may be lower than for laparotomy: a narrative review. Surg. Endosc. 2020; Mintz Y, Arezzo A, Boni L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458289 15. Liver injury in COVID-19: The current evidence. United European Gastroenterol J 2020; 8:509- 519Alqahtani SA, Schattenberg JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450787

Guidelines -Consensus (23 articles)

1. Emergency Radiology During the COVID-19 Pandemic: The Canadian Association of Radiologists Recommendations for Practice. Can Assoc Radiol J 2020:846537120930344Redmond CE, Nicolaou S, Berger FH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468845 2. Practical Guidance for Outpatient Spasticity Management during the Coronavirus (COVID-19) Pandemic: Canadian Spasticity COVID-19 Task Force. Can. J. Neurol. Sci. 2020:1-17Reebye R, Finlayson H, May C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450934 3. Recommendations for the use of vascular access in the COVID-19 patients: an Italian perspective. Crit Care 2020; 24:269Pittiruti M, Pinelli F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466803 4. COVID-19 guidelines for the prioritization of operations for malignant thoracic diseases. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2020; Hekmat K, Bruns CJ. 5. Rapid guide to the management of cardiac patients during the COVID-19 pandemic in Egypt: "a position statement of the Egyptian Society of Cardiology". Egypt Heart J 2020; 72:30Shaheen S, Awwad O, Shokry K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462497 6. Evaluation of World Health Organization-Recommended Hand Hygiene Formulations. Emerg Infect Dis 2020; 26Suchomel M, Eggers M, Maier S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459621 7. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer. ESMO Open 2020; 5Vecchione L, Stintzing S, Pentheroudakis G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457036 8. Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020; Zhang Y, Stewart Coats AJ, Zheng Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463543 9. Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia during the COVID-19 Pandemic: A Living Document. Heart Lung Circ. 2020; Kumar S, Haqqani H, Wynn G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451232 10. CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic. Heart Lung Circ. 2020; Wahi S, Thomas L, Stanton T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467031 11. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations. Hepatol Int 2020; Lau G, Sharma M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447721 12. Evolving consensus on managing vitreo-retina and uvea practice in post-COVID-19 pandemic era. Indian J Ophthalmol 2020; 68:962-973Gupta V, Rajendran A, Narayanan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461407 13. Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR). Int. J. Cardiovasc. Imaging 2020; Beitzke D, Salgado R, Francone M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451877 14. International Guidelines And Recommendations For Surgery During Covid-19 Pandemic: A Systematic Review. Int J Surg 2020; Moletta L, Pierobon ES, Capovilla G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454253 15. SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Societa Italiana di Andrologia e Medicina della Sessualita). J. Endocrinol. Invest. 2020; Corona G, Baldi E, Isidori AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462316 16. Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience. J Infect Public Health 2020; Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451260 17. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci 2020; 414:116884Roman GC, Spencer PS, Reis J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464367 18. Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection. Med. Intensiva 2020; Martin Delgado MC, Aviles- Jurado FX, Alvarez Escudero J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466990 19. Guidance for Resumption of Routine Electrodiagnostic Testing during the COVID-19 Pandemic. Muscle Nerve 2020; Desai U, Kassardjian CD, Del Toro D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462675 20. Virtual Dysphagia Evaluation: Practical Guidelines for Dysphagia Management in the Context of the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820931791Soldatova L, Williams C, Postma GN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450732 21. Recommendations for the Treatment of Elderly Patients with COVID-19 from the Taskforce for Gerontopneumology. Pneumologie (Stuttgart, Germany) 2020; Stieglitz S, Frohnhofen H, Netzer N et al. 22. Decision support tool and suggestions for the development of guidelines for the helicopter transport of patients with COVID-19. Scand. J. Trauma Resusc. Emerg. Med. 2020; 28:43Bredmose PP, Diczbalis M, Butterfield E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450877 23. Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety. Vox Sang 2020; Epstein J, Smid M, Wendel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464700

Imaging (12 articles)

1. A Comparison of Clinical and Chest CT Findings in Patients With Influenza A (H1N1) Virus Infection and Coronavirus Disease (COVID-19). AJR Am J Roentgenol 2020:1-7Yin Z, Kang Z, Yang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452731 2. Application of CareDose 4D combined with Karl 3D technology in the low dose computed tomography for the follow-up of COVID-19. BMC Med. Imaging 2020; 20:56Li J, Wang X, Huang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448136 3. COVID-19: Safe Guidelines for Breast Imaging During the Pandemic. Can Assoc Radiol J 2020:846537120928864Seely JM, Scaranelo AM, Yong-Hing C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32452700 4. Imaging evaluation of COVID-19 in the emergency department. Emerg Radiol 2020; Pakray A, Walker D, Figacz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449099 5. Lung ultrasonography in COVID-19: a gamechanger in the Stroke Unit? Eur. J. Neurol. 2020; Lugnan C, Tommasini V, Furlanis G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449272 6. Any unique image biomarkers associated with COVID-19? Eur Radiol 2020; Pu J, Leader J, Bandos A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462445 7. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era. Future Oncol 2020; Veccia A, Kinspergher S, Dipasquale M, Caffo O. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452225 8. CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic. Heart Lung Circ. 2020; Wahi S, Thomas L, Stanton T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467031 9. Progression of CXR features on a COVID-19 survivor. IDCases 2020; 21:e00834Abdelnour LH, Abdalla ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461911 10. Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR). Int. J. Cardiovasc. Imaging 2020; Beitzke D, Salgado R, Francone M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451877 11. COVID-19 - More Lung Pocus and Sparing Use of Stethoscope, Chest X-Ray and Lung CT. Praxis 2020:1-9Osterwalder J. 12. Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19. Ultrasound Med. Biol. 2020; Mongodi S, Orlando A, Arisi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451194

Immune response (11 articles)

1. Immunity-Boosting Spices and the Novel Coronavirus. ACS Chem Neurosci 2020; Elsayed Y, Khan NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452670 2. Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav Immun 2020; Yuan B, Li W, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464158 3. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? Cell Host Microbe 2020; McKechnie JL, Blish CA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464098 4. COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments. Clin Rheumatol 2020; Ouedraogo DD, Tiendrebeogo WJS, Kabore F, Ntsiba H. http://www.ncbi.nlm.nih.gov/pubmed/? term=32472461 5. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis. Diabetes Metab Syndr 2020; 14:713-714Erol A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470851 6. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology 2020; Tan M, Liu Y, Zhou R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460357 7. The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm? Inflamm Res 2020; Bellinvia S, Edwards CJ, Schisano M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32468151 8. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19. J Med Virol 2020; Ni M, Tian FB, Xiang DD, Yu B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470153 9. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS- CoV-2-Related Viruses. mBio 2020; 11Tan Y, Schneider T, Leong M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471829 10. Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists. Med. Hypotheses 2020; 143:109871Allahverdi Khani M, SalehiRad M, Darbeheshti S, Motaghinejad M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470789 11. Cytokine storm in COVID-19 and parthenolide: preclinical evidence. Phytother. Res. 2020; Bahrami M, Kamalinejad M, Latifi SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472655

Management – misc. diseases (88 articles)

1. Delayed Diagnosis of Pediatric Appendicitis during the COVID-19 Pandemic. Acta Paediatr 2020; Snapiri O, Rosenberg Danziger C, Krause I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460364 2. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin. Exp. Res. 2020; Palmer K, Monaco A, Kivipelto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458356 3. Critical medication shortages further dwindling hospital resources during COVID-19. Am J Emerg Med 2020; Farrell NM, Hayes BD, Linden JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471781 4. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann. Clin. Microbiol. Antimicrob. 2020; 19:21Togun T, Kampmann B, Stoker NG, Lipman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446305 5. Out of Hospital Management of LVAD Patients During COVID-19 Outbreak. Artif. Organs 2020; Mariania S, Schmittoa JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464685 6. Can you draw the picture of happiness- Treatment of a young woman with breast cancer during the COVID-19 pandemic. Asian J Psychiatr 2020; 52:102174Cetin B, Rakici S, Gumusay O. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464519 7. Hemato- Oncology Care in COVID-19 Pandemic: Crisis within a Crisis. Asian Pac J Cancer Prev 2020; 21:1173-1175Seth T, Shankar A, Roy S, Saini D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458618 8. Our First Month of Delivering the Prostate Cancer Diagnostic Pathway within the Limitations of COVID-19 Using Local Anaesthetic Transperineal Biopsy. BJU Int 2020; Popert R, Kum F, MacAskill F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455471 9. Emergency Radiology During the COVID-19 Pandemic: The Canadian Association of Radiologists Recommendations for Practice. Can Assoc Radiol J 2020:846537120930344Redmond CE, Nicolaou S, Berger FH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468845 10. Practical Guidance for Outpatient Spasticity Management during the Coronavirus (COVID-19) Pandemic: Canadian Spasticity COVID-19 Task Force. Can. J. Neurol. Sci. 2020:1-17Reebye R, Finlayson H, May C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450934 11. Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic. Cancer Causes Control 2020; Ip EC, Lee SF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472231 12. The impact of the COVID-19 pandemic on renal transplantation in the UK. Clin Med (Lond) 2020; Sharma V, Shaw A, Lowe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457133 13. COVID-19 and Asthma: Reflection During the Pandemic. Clin. Rev. Allergy Immunol. 2020; Liu S, Zhi Y, Ying S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468411 14. Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity. Clin Rheumatol 2020; Minniti A, Maglione W, Pignataro F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462423 15. Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid. Clin. Transl. Oncol. 2020; Rogado J, Obispo B, Pangua C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449128 16. Successful Conservative Management of Acute Appendicitis in a Coronavirus Disease 2019 (COVID- 19) Patient. Cureus 2020; 12:e7834Suwanwongse K, Shabarek N. http://www.ncbi.nlm.nih.gov/pubmed/? term=32467809 17. The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population. Curr. Oncol. Rep. 2020; 22:60Asokan I, Rabadia SV, Yang EH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462289 18. Novel Coronavirus (COVID-19) and Dentistry-A Comprehensive Review of Literature. Dent J (Basel) 2020; 8Barabari P, Moharamzadeh K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455612 19. COVID-19 guidelines for the prioritization of operations for malignant thoracic diseases. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2020; Hekmat K, Bruns CJ. 20. How badly is the coronavirus pandemic affecting orthopaedic and trauma surgery clinics? : An analysis of the first 5 weeks. Der Orthopade 2020; von Dercks N, Körner C, Heyde CE, Theopold J. 21. Patients with bullous disorders during COVID-19 period: management and adherence to treatment. Dermatol Ther 2020:e13697De Fata Salvatores G, Villani A, Fabbrocini G, Di Guida A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458422 22. Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days. Dermatol Ther 2020:e13686Karadag AS, Aslan Kayiran M, Lotti T, Wollina U. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458530 23. Is climate change the next pandemic for dermatology? Lessons from COVID-19. Dermatol Ther 2020; Patruno C, Nistico SP, Fabbrocini G, Napolitano M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447805 24. Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID-19 pandemic. Dermatol Ther 2020; Ricardo JW, Lipner SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458536 25. Restructuring an Academic Dermatology Practice During the COVID-19 Pandemic. Dermatol Ther 2020; Sheriff T, Murrell OG, Murrell DF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458551 26. Waiting for the surge: COVID-19 patients in the intensive care unit - An overview. Deutsche Apotheker Zeitung 2020; 60Stahl V. 27. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer. ESMO Open 2020; 5Vecchione L, Stintzing S, Pentheroudakis G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457036 28. Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey. Eur J Nucl Med Mol Imaging 2020; Annunziata S, Bauckneht M, Albano D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462398 29. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness? Eur. J. Ophthalmol. 2020:1120672120929961Arrigo A, Aragona E, Parodi MB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32450718 30. Hematopoietic stem cell transplantation dilemma during the COVID-19 era. Future Oncol 2020; Samaha R, Kattan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458703 31. Evolving consensus on managing vitreo-retina and uvea practice in post-COVID-19 pandemic era. Indian J Ophthalmol 2020; 68:962-973Gupta V, Rajendran A, Narayanan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461407 32. The role of a Coronavirus disease 2019 pharmacist: an Australian perspective. Int J Clin Pharm 2020; Nguy J, Hitchen SA, Hort AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472325 33. From high volume to "zero" proctology: Italian experience in the COVID era. Int. J. Colorectal Dis. 2020; Mascagni D, Eberspacher C, Mascagni P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32468103 34. Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment. Int J Environ Res Public Health 2020; 17Bizzoca ME, Campisi G, Muzio LL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471083 35. COVID-19 Disease in Children: What Dentists Should Know and Do to Prevent Viral Spread. The Italian Point of View. Int J Environ Res Public Health 2020; 17Ferrazzano GF, Ingenito A, Cantile T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455859 36. The Precautions Required for the Safe Return of Elective Surgery - A Letter to the Editor in Response to "Impact of the coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation)". Int J Surg 2020; Cheng SO, Liu A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450264 37. International Guidelines And Recommendations For Surgery During Covid-19 Pandemic: A Systematic Review. Int J Surg 2020; Moletta L, Pierobon ES, Capovilla G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454253 38. Staying home during "COVID-19" decreased fractures, but trauma did not quarantine in one hundred and twelve adults and twenty eight children and the "tsunami of recommendations" could not lockdown twelve elective operations. Int. Orthop. 2020; Hernigou J, Morel X, Callewier A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451655 39. A clinical pathway for pre-operative screening of COVID-19 and its influence on clinical outcome in patients with traumatic fractures. Int. Orthop. 2020; Meng Y, Leng K, Shan L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468202 40. Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours. Int. Orthop. 2020; Thaler M, Khosravi I, Leithner A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451657 41. Challenges and response in the medical management of the orthopaedic department during the coronavirus disease 2019 pandemic: strategies in Wuhan, China. Int. Orthop. 2020; Wu W, Xiong W, Kang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468201 42. Changes of clinical activities in an orthopaedic institute in North Italy during the spread of COVID- 19 pandemic: a seven-week observational analysis. Int. Orthop. 2020; Zagra L, Faraldi M, Pregliasco F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449043 43. Survival strategy of urology department during the COVID-19 era. Int. Urol. Nephrol. 2020; Choi SY, Kim TH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472250 44. The impact of COVID-19 on urologic practice, medical education, and training. Int. Urol. Nephrol. 2020; Diokno AC, Devries JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468167 45. A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract 2020; Searing DA, Dutmer CM, Fleischer DM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32450236 46. Rescheduling Nonurgent Care in Radiology: Implementation During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Radiol 2020; Vagal A, Mahoney M, Allen B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473108 47. Preparedness and disinfection of anesthetic equipment in COVID-19. J. Clin. Anesth. 2020; 66:109924Duan N, Gao W, Wang Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473502 48. Preoperative assessment organization in the time of the outbreak COVID-19. J. Clin. Anesth. 2020; 65:109882Elkoundi A, Jaafari A, Ababou M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447166 49. Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach. J Clin Med 2020; 9Wang T, Liu S, Joseph T, Lyou Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455894 50. Aesthetic dermatology procedures in coronavirus-days. J Cosmet Dermatol 2020; Tursen U, Tursen B, Lotti T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460391 51. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID- 19 Outcomes. J. Cutan. Med. Surg. 2020:1203475420929250Nassim D, Jfri A, Litvinov IV, Netchiporouk E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449619 52. Use of systemic therapies for psoriasis in the COVID-19 era. J Dermatolog Treat 2020:1-14Kearns DG, Uppal S, Chat VS, Wu JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459567 53. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities. J Eur Acad Dermatol Venereol 2020; Rossi E, Trakatelli M, Giacomelli L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32455485 54. The role of the orthopaedic surgeon in the COVID-19 era: cautions and perspectives. J Exp Orthop 2020; 7:35Ambrosio L, Vadala G, Russo F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458150 55. COVID-19 risk contagion: Organization and procedures in a South Italy geriatric oncology ward. J. Geriatr. Oncol. 2020; Gambardella C, Pagliuca R, Pomilla G, Gambardella A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467027 56. An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise. J Hepatol 2020; Chew CA, Iyer SG, Chieh Kow AW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454041 57. Coronavirus Disease (COVID-19) Outbreak and Its Impact on Spinal Daily Practice : Preliminary Report from a Single (Regional) University Hospital in Republic of Korea. J. Korean Neurosurg. Soc. 2020; Ham CH, Moon HJ, Kim JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455517 58. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic. J. Med. Toxicol. 2020; Fox ER, Stolbach AI, Mazer-Amirshahi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458230 59. Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond. J. Natl. Cancer Inst. 2020; Freedman RA, Sedrak MS, Bellon JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449757 60. Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J Pharm Policy Pract 2020; 13:18Elbeddini A, Yeats A, Lee S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454982 61. Economic implications of the COVID-19 pandemic on the plastic surgery community. J. Plast. Reconstr. Aesthet. Surg. 2020; Inglesby DC, Boyd CJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471766 62. Reply to Re: COVID-19 and the Urology Match: Perspectives and a Call to Action. J Urol 2020:101097ju0000000000001146Gabrielson AT, Kohn TP, Clifton MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459557 63. Re: COVID-19 and the Urology Match: Perspectives and a Call To Action. J Urol 2020:101097ju0000000000001145Warren CJ, Davis M, Sadeghi-Nejad H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459548 64. Endocrine surgery during and after the COVID-19 epidemic: Expert guidelines from AFCE. J Visc Surg 2020; Baud G, Brunaud L, Lifante JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448761 65. How and why are rheumatologists relevant to COVID-19? Joint Bone Spine 2020; Felten R, Chatelus E, Arnaud L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451147 66. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020. Joint Bone Spine 2020; Richez C, Flipo RM, Berenbaum F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473418 67. Cancer treatment during COVID-19 pandemic. Med. Oncol. 2020; 37:58Jindal V, Sahu KK, Gaikazian S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472216 68. Care of ophthalmological patients during the COVID-19 pandemic: A rapid scoping review. Medwave 2020; 20:e7902Vargas-Peirano M, Navarrete P, Diaz T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469854 69. Guidance for Resumption of Routine Electrodiagnostic Testing during the COVID-19 Pandemic. Muscle Nerve 2020; Desai U, Kassardjian CD, Del Toro D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462675 70. A Structured Approach for Safely Reintroducing Bariatric Surgery in a COVID-19 Environment. Obes. Surg. 2020; Daigle CR, Augustin T, Wilson R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32458364 71. The Impact of the Pandemic on Otolaryngology Patients With Negative COVID-19 Status: Commentary and Insights From Orbital Emergencies. Otolaryngol Head Neck Surg 2020:194599820931082Fastenberg JH, Bottalico D, Kennedy WA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450752 72. Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19. Otolaryngol Head Neck Surg 2020:194599820931801Riestra-Ayora J, Yanes-Diaz J, Penuelas O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450761 73. Endoscopic Skull Base Surgery Protocol From the Frontlines: Transnasal Surgery During the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820931836Spock T, Kessler R, Lerner D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452722 74. Implementation of Preoperative Screening Protocols in Otolaryngology During the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820931041Urban MJ, Patel TR, Raad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452746 75. Evolving Management of COVID-19: A Multi-institutional Otolaryngology Perspective. Otolaryngol Head Neck Surg 2020:194599820930244Wickemeyer JL, Billings KR, Valika TS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450770 76. CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC. PDA J. Pharm. Sci. Technol. 2020; Cundell AM, Guilfoyle DE, Kreil TR, Sawant A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467176 77. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies. Res Social Adm Pharm 2020; Badreldin HA, Atallah B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446652 78. Modifications of emergency dental clinic protocols to combat COVID-19 transmission. Spec. Care Dentist. 2020; Long RH, Ward TD, Pruett ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447777 79. Clinical recommendations on lung cancer management during the COVID-19 pandemic. Thorac Cancer 2020; Xu Y, Liu H, Hu K, Wang M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469164 80. The COVID-19 Pandemic from an Ophthalmologist's Perspective. Trends Mol. Med. 2020; 26:529- 531Bacherini D, Biagini I, Lenzetti C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470381 81. Challenges in Tuberculosis Clinical Trials in the Face of the COVID-19 Pandemic: A Sponsor's Perspective. Trop Med Infect Dis 2020; 5Rusen ID. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471274 82. Elective lung cancer surgery in the COVID-19 era: how do we do it? Tumori 2020:300891620931568Bilkhu R, Bille A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462984 83. Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery. Updates Surg. 2020; Aldrighetti L, Boggi U, Falconi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472403 84. Emergency general surgery in Italy during the COVID-19 outbreak: first survey from the real life. World J Emerg Surg 2020; 15:36Patriti A, Baiocchi GL, Catena F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448333 85. The impact of COVID-19 pandemic on urological emergencies: a single-center experience. World J. Urol. 2020; Motterle G, Morlacco A, Iafrate M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447443 86. An Australian Response to the COVID-19 Pandemic and its Implications on the Practice of Neurosurgery. World Neurosurg 2020; Antony J, James WT, Neriamparambil AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450310 87. Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins Experience. World Neurosurg 2020; Khalafallah AM, Jimenez AE, Lee RP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32461176 88. Impact of the COVID-19 Pandemic on Neurosurgical Practice at an Academic Tertiary Referral Center: A Comparative Study. World Neurosurg 2020; Noureldine MHA, Pressman E, Krafft PR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450314

Management (35 articles)

1. [COVID-19 and The Invisible Damage: The Role of The Family Physician]. Acta Med Port 2020; Gouveia M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459169 2. Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. Am. J. Epidemiol. 2020; Risch HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458969 3. Airway management team for patients with COVID-19: A new role for emergency medicine pharmacists. Am. J. Health Syst. Pharm. 2020; Faine BA, Carroll E, Decleene J, Zepeski A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462173 4. Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the pre-pandemic phase in Hong Kong. Am. J. Infect. Control 2020; Cheng VCC, Wong SC, Chuang VWM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461068 5. Comparison of three tracheal intubation methods for reducing droplet spread for use in COVID-19 patients. Br J Anaesth 2020; Yang SS, Zhang M, Chong JJR. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448441 6. Therapeutic alternatives and strategies for drug conservation in the intensive care unit during times of drug shortage: a report of the Ontario COVID-19 ICU Drug Task Force. Can J Anaesth 2020; Kanji S, Burry L, Williamson D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458267 7. Clinical Outcomes of COVID-19 with Evidence-Based Supportive Care. Clin Infect Dis 2020; Larson DT, Sherner JH, Gallagher KM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472675 8. Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review. Clin Rheumatol 2020; Dai J, Xiong Y, Li H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451729 9. Treatment algorithm for COVID-19: a multidisciplinary point of view. Clin Rheumatol 2020; Galluccio F, Ergonenc T, Garcia Martos A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472459 10. Effect of flow and cannula size on generated pressure during nasal high flow. Crit Care 2020; 24:248Pinkham M, Tatkov S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448344 11. Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series. Crit Care 2020; 24:250Xu Q, Wang T, Qin X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448330 12. Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments. Crit. Rev. Oncol. Hematol. 2020; 151:102982Jafari A, Dadkhahfar S, Perseh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460133 13. Do not discontinue ACE inhibitors and sartans!: RAS inhibitors could even protect hypertensive patients against severe COVID-19 progressions. Deutsche Apotheker Zeitung 2020; 60. 14. COVID-19 Triage: Who is an inpatient? The Essen triage model. Deutsche medizinische Wochenschrift (1946) 2020; Fistera D, Risse J, Manegold R et al. 15. Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers. Deutsche medizinische Wochenschrift (1946) 2020; 145:682-686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F. 16. COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg. Deutsche medizinische Wochenschrift (1946) 2020; 145:657-664Rieg S, Busch HJ, Hans F et al. 17. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review. Dysphagia 2020; Frajkova Z, Tedla M, Tedlova E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468193 18. Indications and timing for tracheostomy in patients with SARS CoV2-related. Eur Arch Otorhinolaryngol 2020; Ferri E, Boscolo Nata F, Pedruzzi B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32458121 19. Analysis of SARS-CoV-2 Screening Clinic (Including Drive-Through System) Data at a Single University Hospital in South Korea from 27 January 2020 to 31 March 2020 during the COVID-19 Outbreak. Healthcare (Basel) 2020; 8Chang MC, Seo WS, Park D, Hur J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466523 20. Evaluation of fluid responsiveness during COVID-19 pandemic: what are the remaining choices? J. Anesth. 2020; Hasanin A, Mostafa M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451626 21. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19. J. Cardiovasc. Transl. Res. 2020; Fudim M, Qadri YJ, Ghadimi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458400 22. Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient. J Med Virol 2020; Ma SQ, Zhang J, Wang YS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470160 23. Palliative Care Utilization among Patients with COVID-19 in an Underserved Population: A Single- Center Retrospective Study. J Pain Symptom Manage 2020; Haydar A, Lo KB, Goyal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454186 24. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J. Thromb. Thrombolysis 2020; Artifoni M, Danic G, Gautier G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451823 25. Nutrition Therapy in Critically Ill Patients with Coronavirus Disease (COVID-19). JPEN J. Parenter. Enteral Nutr. 2020; Martindale R, Patel JJ, Taylor B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462719 26. Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea. Korean J. Intern. Med. 2020; Choe PG, Kang EK, Lee SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460457 27. Management of Upper Airway Bleeding in COVID-19 Patients on Extracorporeal Membrane Oxygenation. Laryngoscope 2020; LoSavio PS, Patel T, Urban MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470179 28. Virtual Dysphagia Evaluation: Practical Guidelines for Dysphagia Management in the Context of the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820931791Soldatova L, Williams C, Postma GN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450732 29. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol. Res. 2020:104950Viecca M, Radovanovic D, Forleo GB, Santus P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450344 30. Food as medicine: a possible preventive measure against coronavirus disease (COVID-19). Phytother. Res. 2020; Fan Y, Zhang Y, Tariq A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468635 31. Prevention is life- and cost-saving. Prev. Med. 2020:106150Baussano I, Sankaranarayanan R, Weiderpass E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473263 32. Prone positioning to improve oxygenation and relieve respiratory symptoms in awake, spontaneously breathing non-intubated patients with COVID-19 pneumonia. Respir Med Case Rep 2020; 30:101096Sztajnbok J, Maselli-Schoueri JH, Cunha de Resende Brasil LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455107 33. Decision support tool and suggestions for the development of guidelines for the helicopter transport of patients with COVID-19. Scand. J. Trauma Resusc. Emerg. Med. 2020; 28:43Bredmose PP, Diczbalis M, Butterfield E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450877 34. COVID-19 in Singapore - a case series from primary care. Singapore Med J 2020; Sim SZ, Teo SH, Kong JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460453 35. [Management of coronavirus disease 2019 (COVID-19): experiences from imported malaria control in China]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:113-118Liu YB, Cao J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458598

Mental – public health (47 articles)

1. Uptrend in distress and psychiatric symptomatology in pregnant women during the COVID-19 pandemic. Acta Obstet Gynecol Scand 2020; Berthelot N, Lemieux R, Garon-Bissonnette J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449178 2. Why all COVID-19 hospitals should have mental health professionals: The importance of mental health in a worldwide crisis! Asian J Psychiatr 2020; 51:102147Grover S, Dua D, Sahoo S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473537 3. Mental health and COVID-19 in Nepal: A case of a satellite clinic. Asian J Psychiatr 2020; 53:102175Sharma P, Joshi D, Shrestha K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450492 4. COVID-19-related anxiety predicts somatic symptoms in the UK population. Br. J. Health Psychol. 2020; Shevlin M, Nolan E, Owczarek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458550 5. Depression and anxiety among adolescents during COVID-19: A cross-sectional study. Brain Behav Immun 2020; Chen F, Zheng D, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464156 6. Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav Immun 2020; Yuan B, Li W, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464158 7. Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea. Clin Infect Dis 2020; Lee H, Lee H, Song KH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472687 8. COVID-19 Crisis: Early Observations on a Pandemic's Psychiatric Problems. Deutsche medizinische Wochenschrift (1946) 2020; 145:675-681Fatke B, Hölzle P, Frank A, Förstl H. 9. [Responsiveness and sustainability of psychiatric care in France during COVID-19 epidemic]. Encephale 2020; Bocher R, Jansen C, Gayet P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471705 10. [Suicidal behavior in light of COVID-19 outbreak: Clinical challenges and treatment perspectives]. Encephale 2020; Conejero I, Berrouiguet S, Ducasse D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471707 11. Neuropsychiatric symptoms and quality of life in Spanish Alzheimer's disease patients during COVID-19 lockdown. Eur. J. Neurol. 2020; Beatriz Lara B, Carnes A, Dakterzada F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449791 12. Stress resilience during the coronavirus pandemic. Eur. Neuropsychopharmacol. 2020; Vinkers CH, van Amelsvoort T, Bisson JI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446705 13. Covid-19 and the Subsequent Lockdown Modified Dietary Habits of Almost Half the Population in an Italian Sample. Foods 2020; 9Scarmozzino F, Visioli F. http://www.ncbi.nlm.nih.gov/pubmed/? term=32466106 14. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. Gen. Hosp. Psychiatry 2020; 65:47-53Beach SR, Praschan NC, Hogan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470824 15. Public Mental Health as One of the Key Factors in Dealing with COVID-19. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2020; Hahad O, Gilan DA, Daiber A, Münzel T. 16. The effects of COVID-19 on the health and socio-economic security of sex workers in Nairobi, Kenya: Emerging intersections with HIV. Glob Public Health 2020:1-10Kimani J, Adhiambo J, Kasiba R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459578 17. Impact of COVID-19 on the mental health of surgeons and coping strategies. Head Neck 2020; Balasubramanian A, Paleri V, Bennett R, Paleri V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462783 18. COVID-19 pandemic, socioeconomic crisis and human stress in resource-limited settings: A case from Bangladesh. Heliyon 2020; 6:e04063Shammi M, Bodrud-Doza M, Towfiqul Islam ARM, Rahman MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462098 19. Compliance and Psychological Impact of Quarantine in Children and Adolescents due to Covid-19 Pandemic. Indian J Pediatr 2020; Saurabh K, Ranjan S. http://www.ncbi.nlm.nih.gov/pubmed/? term=32472347 20. Psychological status and behavior changes of the public during the COVID-19 epidemic in China. Infect Dis Poverty 2020; 9:58Liu X, Luo WT, Li Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471513 21. Digital technology can revolutionize mental health services delivery: The COVID-19 crisis as a catalyst for change. Int. J. Eat. Disord. 2020; Taylor CB, Fitzsimmons-Craft EE, Graham AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449523 22. Conducting eating disorders research in the time of COVID-19: A survey of researchers in the field. Int. J. Eat. Disord. 2020; Weissman RS, Klump KL, Rose J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449555 23. Depression and Anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health 2020; 17Choi EPH, Hui BPH, Wan EYF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466251 24. The Psychological Impact of Confinement Linked to the Coronavirus Epidemic COVID-19 in Algeria. Int J Environ Res Public Health 2020; 17Madani A, Boutebal SE, Bryant CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455550 25. A Multidimensional Model of Public Health Approaches Against COVID-19. Int J Environ Res Public Health 2020; 17Nazir M, Hussain I, Tian J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466581 26. Changes in Provision of Psychotherapy in the Early Weeks of the COVID-19 Lockdown in Austria. Int J Environ Res Public Health 2020; 17Probst T, Stippl P, Pieh C. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471295 27. The Mental Health Burden of the COVID-19 Pandemic on Physical Therapists. Int J Environ Res Public Health 2020; 17Yang S, Kwak SG, Ko EJ, Chang MC. http://www.ncbi.nlm.nih.gov/pubmed/? term=32466164 28. Domestic violence amid COVID-19. Int J Gynaecol Obstet 2020; Anurudran A, Yared L, Comrie C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472696 29. Mental Health Impacts of COVID-19 in Ireland and the Need for a Secondary Care, Mental Health Service Response. Ir. J. Psychol. Med. 2020:1-18O'Connor K, Wrigley M, Jennings R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456713 30. The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors. Ital. J. Pediatr. 2020; 46:69Buzzi C, Tucci M, Ciprandi R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448323 31. Impact of the COVID-19 Pandemic on Mental Health and Social Support among Adult Egyptians. J. Community Health 2020; El-Zoghby SM, Soltan EM, Salama HM. http://www.ncbi.nlm.nih.gov/pubmed/? term=32468155 32. The Emergence of COVID-19 in the U.S.: A Public Health and Political Communication Crisis. J. Health Polit. Policy Law 2020; Gollust SE, Nagler RH, Fowler EF. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464658 33. Federalism Complicates the Response to the COVID-19 Health and Economic Crisis: What Can Be Done? J. Health Polit. Policy Law 2020; Huberfeld N, Gordon SH, Jones DK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464666 34. Democracy, Capacity, and Coercion in Pandemic Response-COVID 19 in Comparative Political Perspective. J. Health Polit. Policy Law 2020; Kavanagh MM, Singh R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464665 35. Health Equity, Social Policy, and Promoting Recovery from COVID-19. J. Health Polit. Policy Law 2020; Lynch J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464651 36. Disaster Preparedness and Social Justice in a Public Health Emergency. J. Health Polit. Policy Law 2020; Pollack HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464639 37. Child protection in the time of COVID-19. J. Paediatr. Child Health 2020; S SST, Griffiths G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468616 38. The impact of having inadequate safety equipment on mental health. Occup. Med. (Lond.) 2020; Simms A, Fear NT, Greenberg N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449770 39. Impact of coronavirus pandemic in appointments and anxiety/concerns of patients regarding orthodontic treatment. Orthod. Craniofac. Res. 2020; Cotrin PP, Peloso RM, Oliveira RC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449999 40. Public and Private Health Services: Wait Times for Health Services and the Risk of Inequality from the Italian Perspective. Popul Health Manag 2020; Cioffi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32466717 41. Accountability to Population Health in the COVID-19 Pandemic: Designing Health Care Delivery Within a Social Responsibility Framework. Popul Health Manag 2020; Cutter CM, Nelson C, Abir M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463721 42. Rapid Conversion of an Outpatient Psychiatric Clinic to a 100% Virtual Telepsychiatry Clinic in Response to COVID-19. Psychiatr. Serv. 2020:appips202000230Yellowlees P, Nakagawa K, Pakyurek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460683 43. University students' mental health amidst the COVID-19 quarantine in Greece. Psychiatry Res 2020; 290:113111Kaparounaki CK, Patsali ME, Mousa DV et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32450416 44. Clinically significant fear and anxiety of COVID-19: A psychometric examination of the Coronavirus Anxiety Scale. Psychiatry Res 2020; 290:113112Lee SA, Mathis AA, Jobe MC, Pappalardo EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460185 45. [About public health communication strategies and campaigns: what do you know about 2019- nCoV?]. Rev. Esp. Salud Publica 2020; 94:e1-e2Bilbatua Andres J, Mudaber J, Jimenez-Vargas D, Arrieta Angulo B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452469 46. [Application and thinking of health standards related to public health in prevention and control of coronavirus disease 2019]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:E068Xu X, Jiang YC, Yang YQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455512 47. [Application and thinking of health standards related to medical care and health information etc. in prevention and control of COVID-19]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:E069Xu X, Yang YQ, Jiang YC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455513

Meta-analyses - systematic reviews (5 articles)

1. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review. Clin Microbiol Infect 2020; Rodrigo C, Fernando SD, Rajapakse S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470568 2. The association of low serum albumin level with severe COVID-19: a systematic review and meta- analysis. Crit Care 2020; 24:255Aziz M, Fatima R, Lee-Smith W, Assaly R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456658 3. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 2020; Jain V, Yuan JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451563 4. Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med 2020; 9Ang L, Song E, Lee HW, Lee MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456123 5. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020; Lansbury L, Lim B, Baskaran V, Lim WS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473235

Mortality (9 articles)

1. Age-related difference in the rate of COVID-19 mortality in women versus men. Am J Obstet Gynecol 2020; Cagnacci A, Xholli A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460973 2. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant. Eur J Heart Fail 2020; Benzakoun J, Hmeydia G, Delabarde T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463538 3. [Impact of COVID-19 on mortality in the autonomous community of Castilla y Leon (Spain)]. Gac. Sanit. 2020; Ochoa Sangrador C, Garmendia Leiza JR, Perez Boillos MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446595 4. Deaths in nine regions of Italy in February/March 2020: "Mortality Excess Loupe" for SARS-CoV- 2/COVID-19-Epidemiology in Germany. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2020; Morfeld P, Erren TC. 5. Maternal mortality from COVID-19 in Mexico. Int J Gynaecol Obstet 2020; Lumbreras-Marquez MI, Campos-Zamora M, Lizaola-Diaz de Leon H, Farber MK. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473603 6. COVID-19 Pandemic: Marked Global Disparities in Fatalities According to Geographic Location and Universal Health Care. Int J MCH AIDS 2020; 9:213-216Dongarwar D, Salihu HM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461818 7. Excess mortality from COVID-19: a commentary on the Italian experience. Int J Public Health 2020; Pasquariello P, Stranges S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468219 8. Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters. Open Forum Infect Dis 2020; 7:ofaa152Tian S, Liu H, Liao M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457924 9. COVID-19 Waves: Importance of Accumulative Mortality per Million Inhabitants. Tohoku J. Exp. Med. 2020; 251:47-49Delgado CA, Shimabuku RL, Chiroque-Solano PM. http://www.ncbi.nlm.nih.gov/pubmed/? term=32461502

On-line – IT – Apps (25 articles)

1. YouTube as a source of information on COVID-19 and rheumatic disease link. Clin Rheumatol 2020; Kocyigit BF, Akaltun MS, Sahin AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447603 2. Social Media Data Analytics on Telehealth During the COVID-19 Pandemic. Cureus 2020; 12:e7838Massaad E, Cherfan P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467813 3. Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy. Dermatol Ther 2020:e13495Brunasso AMG, Massone C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458588 4. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med 2020; Stebbing J, Krishnan V, de Bono S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473600 5. Telemedicine in nursing homes during the COVID-19 outbreak: A star is born (again). Geriatr Gerontol Int 2020; Cormi C, Chrusciel J, Laplanche D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462676 6. Tele-consultations and electronic medical records driven remote patient care: Responding to the COVID-19 lockdown in India. Indian J Ophthalmol 2020; 68:1007-1012Das AV, Rani PK, Vaddavalli PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461415 7. Digital technology can revolutionize mental health services delivery: The COVID-19 crisis as a catalyst for change. Int. J. Eat. Disord. 2020; Taylor CB, Fitzsimmons-Craft EE, Graham AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449523 8. Healthcare information on YouTube: Pregnancy and COVID-19. Int J Gynaecol Obstet 2020; Yuksel B, Cakmak K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471005 9. Deep learning COVID-19 detection bias: accuracy through artificial intelligence. Int. Orthop. 2020; Vaid S, Kalantar R, Bhandari M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462314 10. Virtualised care and COVID-19. Ir. J. Med. Sci. 2020; MF OR, Merghani K, Sheehan E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468414 11. An AI approach to COVID-19 infection risk assessment in virtual visits: a case report. J Am Med Inform Assoc 2020; Obeid JS, Davis M, Turner M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449766 12. Veterans' Response to an Automated Text Messaging Protocol During the COVID-19 Pandemic. J Am Med Inform Assoc 2020; Saleem JJ, Read JM, Loehr BM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470974 13. Benefits of Technology in the Age of COVID-19 and Diabetes. . .Mobile Phones From a Rwanda Perspective. J. Diabetes Sci. Technol. 2020:1932296820930032Krisiunas E, Sibomana L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460536 14. Diabetes and Technology in the Covid-19 Pandemic Crisis. J. Diabetes Sci. Technol. 2020:1932296820929385Spanakis EK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460544 15. COVID-19, Type 1 Diabetes Clinical Practice, Research, and Remote Medical Care: A View From the Land Down-Under. J. Diabetes Sci. Technol. 2020:1932296820929708Venkatesh N, Paldus B, Lee MH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468858 16. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review. J Med Syst 2020; 44:122Albahri AS, Hamid RA, Alwan JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451808 17. Teleneurology during the COVID-19 pandemic: A step forward in modernizing medical care. J Neurol Sci 2020; 414:116930Roy B, Nowak RJ, Roda R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32460041 18. COVID-19: Putting the General Data Protection Regulation to the Test. JMIR Public Health Surveill 2020; 6:e19279McLennan S, Celi LA, Buyx A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449686 19. Implementation and analysis of a telephone support service during COVID-19. Occup. Med. (Lond.) 2020; Matthewson J, Tiplady A, Gerakios F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449754 20. Video Conferencing in the Intravitreal Injection Clinic in Response to the COVID-19 Pandemic. Ophthalmol Ther 2020; Saedon H, Gould G, Begum M, Aslam TM. http://www.ncbi.nlm.nih.gov/pubmed/? term=32451906 21. A telemedicina lehetosegei a COVID-19-pandemia kapcsan a nemzetkozi es a magyarorszagi tapasztalatok es ajanlasok tukreben. Orv. Hetil. 2020; 161:983-992Gyorffy Z, Bekasi S, Szathmari- Meszaros N, Nemeth O. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469844 22. Possibilities of telemedicine regarding the COVID-19 pandemic in light of the international and Hungarian experiences and recommendations. Orv. Hetil. 2020; 161:983-992Gyorffy Z, Bekasi S, Szathmari-Meszaros N, Nemeth O. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469844 23. Telemedicine During the COVID-19 Pandemic: A Pediatric Otolaryngology Perspective. Otolaryngol Head Neck Surg 2020:194599820931827Maurrasse SE, Rastatter JC, Hoff SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450755 24. Rapid Conversion of an Outpatient Psychiatric Clinic to a 100% Virtual Telepsychiatry Clinic in Response to COVID-19. Psychiatr. Serv. 2020:appips202000230Yellowlees P, Nakagawa K, Pakyurek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460683 25. Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic. World Neurosurg 2020; Daggubati LC, Eichberg DG, Ivan ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450309

Other – Miscellaneous (31 articles)

1. Distributive justice during the COVID-19 pandemic in Australia. ANZ J Surg 2020; Fisher OM, Brown KG, Coker DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452147 2. How did "flatten the curve" become "flatten the economy?" A perspective from the United States of America. Asian J Psychiatr 2020; 51:102165Jenson HB. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464513 3. The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics amidst a Pandemic. Clin Infect Dis 2020; Streifel AC, Sikka MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463077 4. Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers. Clin. Transl. Oncol. 2020; Pino LE, Triana I, Perez C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32447647 5. Initial evidence on the relationship between the coronavirus pandemic and crime in the United States. Crime Sci 2020; 9:6Ashby MPJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455094 6. The explosion in scabies cases during COVID-19 pandemic. Dermatol Ther 2020; Kutlu O, Aktas H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447797 7. Legal Issues of Resource Allocation in the COVID-19 Pandemic - Between Utilitarianism and Life Value Indifference. Deutsche medizinische Wochenschrift (1946) 2020; 145:687-692Hübner J, Schewe DM, Katalinic A, Frielitz FS. 8. Struggling to get started. Elife 2020; 9Tay A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459175 9. Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration. ESMO Open 2020; 5Palmieri C, Palmer D, Openshaw PJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32457054 10. The role of head and neck cancer advocacy organizations during the COVID-19 pandemic. Head Neck 2020; Yan F, Rauscher E, Hollinger A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468607 11. The Impact of COVID-19 on Tourist Satisfaction with B&B in Zhejiang, China: An Importance- Performance Analysis. Int J Environ Res Public Health 2020; 17Hong Y, Cai G, Mo Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466326 12. Potential Application of Whole Body Vibration Exercise For Improving The Clinical Conditions of COVID-19 Infected Individuals: A Narrative Review From the World Association of Vibration Exercise Experts (WAVex) Panel. Int J Environ Res Public Health 2020; 17Sanudo B, Seixas A, Gloeckl R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455961 13. "COVID-19: Results of a national survey of United Kingdom healthcare professionals' perceptions of current management strategy - a cross-sectional questionnaire study". Int J Surg 2020; Iqbal MR, Chaudhuri A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447002 14. Loud and silent epidemics in the third millennium: tuning-up the volume. Int. Orthop. 2020; Romano CL, Drago L, Del Sel H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449044 15. Willingness of Chinese nurses to practice in Hubei combating the coronavirus disease 2019 epidemic: A cross-sectional study. J. Adv. Nurs. 2020; Gan X, Shi Z, Ying Chair S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449187 16. COVID-19 pandemic and home-based physical activity. J Allergy Clin Immunol Pract 2020; Carvalho VO, Gois CO. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470443 17. The impact of Covid-19 pandemic on corporate social responsibility and marketing philosophy. J Bus Res 2020; 116:176-182He H, Harris L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457556 18. The COVID-19 Pandemic: A "Tech"-tonic Shift Toward Virtual Diabetes Care. J. Diabetes Sci. Technol. 2020:1932296820929719Ahn DT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450726 19. Professional autonomy and liability of the resident doctor: Between the hammer and the anvil. J. Forensic Leg. Med. 2020; 72:101965Cioffi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452455 20. COVID-19 in forensic medicine unit personnel: Observation from Thailand. J. Forensic Leg. Med. 2020; 72:101964Sriwijitalai W, Wiwanitkit V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452454 21. Racism and the Political Economy of COVID-19: Will We Continue to Resurrect the Past? J. Health Polit. Policy Law 2020; Bailey ZD, Moon JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464657 22. Nowhere to hide: The significant impact of coronavirus disease 2019 (COVID-19) measures on elite and semi-elite South African athletes. J. Sci. Med. Sport 2020; Pillay L, Janse van Rensburg DCC, Jansen van Rensburg A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448749 23. COVID-19, quarantine, and atopic dermatitis. Med. Hypotheses 2020; 143:109852Patruno C, Nistico SP, Fabbrocini G, Napolitano M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447099 24. COVID-19 in the UK and Occupational Health and Safety: Predictable not Inevitable Failures by Government, and Trade Union and Nongovernmental Organization Responses. New Solut. 2020:1048291120929763Watterson A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448036 25. Tobacco Use Patterns in five countries during the COVID-19 Lockdown. Nicotine Tob Res 2020; Yach D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459837 26. Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits. Nutrients 2020; 12Martinez-Ferran M, de la Guia-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466598 27. Onkologiai beteg tervezett PET/CT vizsgalata soran veletlenszeruen felfedezett COVID-19-betegseg. Orv. Hetil. 2020; 161:971-976Czibor S, Kristof E, Kecskes K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32453695 28. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben. Orv. Hetil. 2020; 161:899-907Zatroch I, Smudla A, Babik B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453702 29. An Otolaryngologist Redeployed to a COVID-19 Intensive Care Unit: Lessons Learned. Otolaryngol Head Neck Surg 2020:194599820931819Dhar SI. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450756 30. How Strong Is the Duty to Treat in a Pandemic? Ethics in Practice: Point-Counterpoint. Otolaryngol Head Neck Surg 2020:194599820930246Redmann AJ, Manning A, Kennedy A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450750 31. No Participant Left Behind: Conducting Science During COVID-19. Trends Cogn. Sci. 2020; Lourenco SF, Tasimi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451239

Pathology (5 articles)

1. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases. Am J Clin Pathol 2020; Sekulic M, Harper H, Nezami BG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451533 2. Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy. Cancer 2020; Rolfo C, Russo A, de Miguel-Perez D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472948 3. SARS-CoV-2 Persisted in Lung Tissue Despite Disappearance in Other Clinical Samples. Clin Microbiol Infect 2020; Zhao Y, Xia Z, Liang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447048 4. Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis. Nanomaterials (Basel) 2020; 10Cordaro A, Neri G, Sciortino MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466536 5. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients. Ocul Immunol Inflamm 2020:1-5Casagrande M, Fitzek A, Puschel K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469258

Protection (38 articles)

1. Face Mask-induced Itch: A Self-questionnaire Study of 2,315 Responders During the COVID-19 Pandemic. Acta Derm. Venereol. 2020; Szepietowski JC, Matusiak L, Szepietowska M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449781 2. Pretreated household materials carry similar filtration protection against pathogens when compared with surgical masks. Am. J. Infect. Control 2020; Carnino JM, Ryu S, Ni K, Jin Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464294 3. Infection control practices in children during COVID-19 pandemic: differences from adults. Am. J. Infect. Control 2020; Devrim I, Bayram N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464297 4. The impact of novel coronavirus SARS-CoV-2 among healthcare workers in hospitals: An aerial overview. Am. J. Infect. Control 2020; Xiang B, Li P, Yang X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464298 5. Thinking outside the (acrylic) box: a framework for the local use of custom-made medical devices. Anaesthesia 2020; Turner MC, Duggan LV, Glezerson BA, Marshall SD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470144 6. Ultra-portable low-cost improvised powered air-purifying respirator: feasibility study. Br J Anaesth 2020; Khoo D, Yen CC, Chow WT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446500 7. Comparison of three tracheal intubation methods for reducing droplet spread for use in COVID-19 patients. Br J Anaesth 2020; Yang SS, Zhang M, Chong JJR. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448441 8. COVID-19: Safe Guidelines for Breast Imaging During the Pandemic. Can Assoc Radiol J 2020:846537120928864Seely JM, Scaranelo AM, Yong-Hing C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32452700 9. Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 2020; Chan JF, Yuan S, Zhang AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472679 10. Use of an antiviral filter attached to a pleural drain bottle to prevent aerosol contamination with SARS-CoV-2. Clin Med (Lond) 2020; Akhtar MR, Ricketts W, Fotheringham T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457134 11. SARS-CoV-2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit. Clin Microbiol Infect 2020; Colaneri M, Seminari E, Novati S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450255 12. Surgical mask dermatitis caused by formaldehyde (releasers) during the COVID-19 pandemic. Contact Dermatitis 2020; Aerts O, Dendooven E, Foubert K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32468589 13. Universal mobile protection system for aerosol-generating medical interventions in COVID-19 patients. Crit Care 2020; 24:264Straube F, Wendtner C, Hoffmann E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456661 14. Knowledge, Attitude, and Practices of Healthcare Workers Regarding the Use of Face Mask to Limit the Spread of the New Coronavirus Disease (COVID-19). Cureus 2020; 12:e7737Kumar J, Katto MS, Siddiqui AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455057 15. Control measures to prevent Coronavirus disease 2019 COVID-19pandemic in endoscopy centers: a multi-centre study. Dig Endosc 2020; Huang Q, Liu G, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473036 16. Nurse Infected with Covid-19 from a Provisional Dengue Patient. Emerg Microbes Infect 2020:1- 5Prasitsirikul W, Pongpirul K, Pongpirul WA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458742 17. Incidentally discovered COVID-19 in low-suspicion patients-a threat to front line health care workers. Emerg Radiol 2020; Xiao N, Abboud S, McCarthy DM, Parekh N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449100 18. Acetic acid disinfection as a potential adjunctive therapy for non-severe COVID-19. Eur Arch Otorhinolaryngol 2020; Pianta L, Vinciguerra A, Bertazzoni G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449022 19. Management of a delivery suite during the COVID-19 epidemic. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; Qi H, Chen M, Luo X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466867 20. Manufacturing and supply of face shields in hospital operation in case of unclear and confirmed COVID-19 infection status of patients. Eur. J. Trauma Emerg. Surg. 2020; Neijhoft J, Viertmann T, Meier S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462375 21. COVID-19 infections among healthcare workers exposed to a patient with a delayed diagnosis of COVID-19. Infect Control Hosp Epidemiol 2020:1-9Baker MA, Rhee C, Fiumara K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456720 22. Letter to editor - Can universal masking help with our recovery from the COVID-19 pandemic? Int J Surg 2020; Chiang CH, Chiang CH, Chiang CH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450263 23. Commentary on: A Novel solution to the PPE crisis during the Coronavirus pandemic (COVID-19). Int J Surg 2020; Syed DS, Malik MS, Ominu-Evbota K. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470595 24. AVOIDING HEALTH WORKER INFECTION AND CONTAINING THE CORONAVIRUS DISEASE 2019 PANDEMIC: Perspectives from the frontline in Wuhan. Int J Surg 2020; Tang LH, Tang S, Chen XL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454250 25. Providing evidence on the ongoing health care workers' mask debate. Intern Emerg Med 2020; Tsilingiris D, Papatheodoridi M, Kapelios CJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468509 26. New York City COVID-19 resident physician exposure during exponential phase of pandemic. J. Clin. Invest. 2020; Breazzano MP, Shen J, Abdelhakim AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32463802 27. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J. Emerg. Med. 2020; Dockery DM, Rowe SG, Murphy MA, Krzystolik MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456959 28. Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage. J Pharm Policy Pract 2020; 13:19Elbeddini A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454983 29. A Structured Approach for Safely Reintroducing Bariatric Surgery in a COVID-19 Environment. Obes. Surg. 2020; Daigle CR, Augustin T, Wilson R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32458364 30. The impact of having inadequate safety equipment on mental health. Occup. Med. (Lond.) 2020; Simms A, Fear NT, Greenberg N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449770 31. Ventilated Upper Airway Endoscopic Endonasal Procedure Mask: Surgical Safety in the COVID-19 Era. Oper Neurosurg (Hagerstown) 2020; Helman SN, Soriano RM, Tomov ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472685 32. Digital prosthetic workflow during COVID-19 pandemic to limit infection risk in dental practice. Oral Dis 2020; Papi P, Di Murro B, Penna D, Pompa G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460440 33. Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19. Otolaryngol Head Neck Surg 2020:194599820931801Riestra-Ayora J, Yanes-Diaz J, Penuelas O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450761 34. Airborne Aerosol Generation During Endonasal Procedures in the Era of COVID-19: Risks and Recommendations. Otolaryngol Head Neck Surg 2020:194599820931805Workman AD, Jafari A, Welling DB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452739 35. COVID-19 - More Lung Pocus and Sparing Use of Stethoscope, Chest X-Ray and Lung CT. Praxis 2020:1-9Osterwalder J. 36. Safe extubation during the COVID-19 pandemic. Respir. Med. 2020; 170:106038Kangas-Dick AW, Swearingen B, Wan E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469731 37. The risk of COVID-19 transmission by laparoscopic smoke may be lower than for laparotomy: a narrative review. Surg. Endosc. 2020; Mintz Y, Arezzo A, Boni L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458289 38. Preventing transmission among operating room staff during COVID-19 pandemic: the role of the Aerosol Box and other personal protective equipment. Updates Surg. 2020; Bianco F, Incollingo P, Grossi U, Gallo G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449034

Pulmonary disease (4 articles)

1. COVID-19 pneumonia: phenotype assessment requires bedside tools. Crit Care 2020; 24:272Zhao Z, Kung WH, Chang HT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471449 2. Inside the lungs of COVID-19 disease. Int. J. Legal Med. 2020; Aguiar D, Lobrinus JA, Schibler M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458044 3. COVID-19 and asthma: To have or not to have T2 inflammation makes a difference? Pulmonology 2020; Morais-Almeida M, Bousquet J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466999 4. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:E018Jiang SW, Gao H, Wu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455515

Renal disease (9 articles)

1. The impact of the COVID-19 pandemic on renal transplantation in the UK. Clin Med (Lond) 2020; Sharma V, Shaw A, Lowe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457133 2. Presentation and Outcomes of Patients with ESKD and COVID-19. J Am Soc Nephrol 2020; Valeri AM, Robbins-Juarez SY, Stevens JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32467113 3. COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis. Kidney Blood Press. Res. 2020:1- 6Perna AF, Capolongo G, Trepiccione F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450560 4. A view from the front line of the COVID-19 war. Kidney Int 2020; Carrara C, Cappelletti L, Portalupi V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451077 5. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int 2020; Kliger AS, Cozzolino M, Jha V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471637 6. High prevalence of asymptomatic COVID-19 in haemodialysis: learning day by day in the first month of the COVID-19 pandemic. Nefrologia 2020; Albalate M, Arribas P, Torres E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456944 7. [Renal Monomorphology in COVID-19 with Acute Renal Insufficiency]. Praxis (Bern 1994) 2020:1- 5Tuma J, Neugebauer F, Rohacek M, Serra A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469263 8. [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]. Semergen 2020; Pallares Carratala V, Gorriz-Zambrano C, Morillas Arino C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448633 9. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis 2020:e13334Lauterio A, Valsecchi M, Santambrogio S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449235

Reviews (23 articles)

1. Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect 2020; Fragkou PC, Belhadi D, Peiffer-Smadja N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454187 2. Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review. Clin Rheumatol 2020; Dai J, Xiong Y, Li H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451729 3. Treatment algorithm for COVID-19: a multidisciplinary point of view. Clin Rheumatol 2020; Galluccio F, Ergonenc T, Garcia Martos A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472459 4. A Review of Neurological Complications of COVID-19. Cureus 2020; 12:e8192Sheraton M, Deo N, Kashyap R, Surani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455089 5. Cutaneous manifestations of COVID-19: A review of the published literature. Dermatol Ther 2020; Elmas OF, Demirbas A, Ozyurt K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458546 6. Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists. Dermatol Ther 2020; Kaur I, Sharma A, Jakhar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447820 7. The new corona virus: many unanswered questions. Deutsche medizinische Wochenschrift (1946) 2020; 145:641Middeke M. 8. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review. Dysphagia 2020; Frajkova Z, Tedla M, Tedlova E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468193 9. Profile and quality of published reviews on COVID-19. Eur. J. Clin. Invest. 2020:e13293Pericas JM, Torrallardona-Murphy O, Arenas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473068 10. Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review. Infect Dis Ther 2020; Fajgenbaum DC, Khor JS, Gorzewski A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462545 11. Non-steroidal anti-inflammatory drugs in management of COVID-19; a systematic review on current evidence. Int J Clin Pract 2020:e13557Yousefifard M, Zali A, Zarghi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460369 12. Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment. Int J Environ Res Public Health 2020; 17Bizzoca ME, Campisi G, Muzio LL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471083 13. The COVID-19 pandemic: is our medicine still evidence-based? Ir. J. Med. Sci. 2020; Deana C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468413 14. COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease. J. Cell. Physiol. 2020; Sheervalilou R, Shirvaliloo M, Dadashzadeh N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452539 15. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19. J. Clin. Pharmacol. 2020; Ren YR, Golding A, Sorbello A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469437 16. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review. J Eur Acad Dermatol Venereol 2020; Docampo-Simon A, Sanchez-Pujol MJ, Juan-Carpena G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452545 17. COVID-19 and pregnancy - where are we now? A review. J. Perinat. Med. 2020; Rajewska A, Mikolajek- Bedner W, Lebdowicz-Knul J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452195 18. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 2020:117839KaviyarasiRenu, Prasanna PL, Abilash VG. http://www.ncbi.nlm.nih.gov/pubmed/? term=32450165 19. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 2020; 255:117839Renu K, Prasanna PL, Valsala Gopalakrishnan A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32450165 20. Care of ophthalmological patients during the COVID-19 pandemic: A rapid scoping review. Medwave 2020; 20:e7902Vargas-Peirano M, Navarrete P, Diaz T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469854 21. COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns. Pain Ther 2020; Pergolizzi JV, Jr., Varrassi G, Magnusson P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447629 22. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses 2020; 12Younes N, Al-Sadeq DW, Al-Jighefee H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466458 23. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J. Urol. 2020; Chan VW, Chiu PK, Yee CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462305

Risk factors (36 articles)

1. An update on ACE2 amplification and its therapeutic potential. Acta Physiol. (Oxf.) 2020:e13513Marquez A, Wysocki J, Pandit J, Batlle D. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469114 2. Why does COVID-19 disproportionately affect older people? Aging (Albany NY) 2020; 12Mueller AL, McNamara MS, Sinclair DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470948 3. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med 2020; Wilkerson RG, Adler JD, Shah NG, Brown R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471783 4. Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. Am. J. Epidemiol. 2020; Risch HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458969 5. Age-related difference in the rate of COVID-19 mortality in women versus men. Am J Obstet Gynecol 2020; Cagnacci A, Xholli A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460973 6. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab 2020; Korakas E, Ikonomidis I, Kousathana F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459524 7. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis 2020; Smadja DM, Guerin CL, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458111 8. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room. Arch Med Res 2020; Assandri R, Buscarini E, Canetta C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471703 9. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 2020; 11:29Gebhard C, Regitz-Zagrosek V, Neuhauser HK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450906 10. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19. Clin Chim Acta 2020; Saadat M. http://www.ncbi.nlm.nih.gov/pubmed/? term=32454047 11. Predictors for Severe COVID-19 Infection. Clin Infect Dis 2020; Bhargava A, Fukushima EA, Levine M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472676 12. The association of low serum albumin level with severe COVID-19: a systematic review and meta- analysis. Crit Care 2020; 24:255Aziz M, Fatima R, Lee-Smith W, Assaly R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456658 13. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis. Diabetes Metab Syndr 2020; 14:713-714Erol A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470851 14. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020; Cariou B, Hadjadj S, Wargny M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472191 15. Overdose and risk factors for coronavirus disease 2019. Drug Alcohol Depend. 2020; 212:108047Slaunwhite AK, Gan WQ, Xavier C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447172 16. Correlation between environmental pollution indicators and COVID-19 pandemic: A brief study in Californian context. Environ. Res. 2020; 187:109652Bashir MF, Ma BJ, Bilal et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454308 17. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? Eur. J. Contracept. Reprod. Health Care 2020:1-2Grandi G, Facchinetti F, Bitzer J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469251 18. The lethal sex gap: COVID-19. Immun. Ageing 2020; 17:13Marquez EJ, Trowbridge J, Kuchel GA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457811 19. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility. Int J Mol Sci 2020; 21Chakladar J, Shende N, Li WT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455539 20. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 2020; Jain V, Yuan JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451563 21. An AI approach to COVID-19 infection risk assessment in virtual visits: a case report. J Am Med Inform Assoc 2020; Obeid JS, Davis M, Turner M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449766 22. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly. J Biol Regul Homeost Agents 2020; 34Englmeier L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456409 23. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID- 19 Outcomes. J. Cutan. Med. Surg. 2020:1203475420929250Nassim D, Jfri A, Litvinov IV, Netchiporouk E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449619 24. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci 2020; Kuo CL, Pilling LC, Atkins JL et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32451547 25. Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019. J Infect Public Health 2020; Peng Y, Xu B, Sun B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451257 26. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. J Korean Med Sci 2020; 35:e195Yoon JG, Yoon J, Song JY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449329 27. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia. J Med Virol 2020; Wang CZ, Hu SL, Wang L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470167 28. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020; 414:116923Jain R, Young M, Dogra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447193 29. The case of Complement activation in COVID-19 multiorgan impact. Kidney Int 2020; Noris M, Benigni A, Remuzzi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461141 30. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr. Metab. Cardiovasc. Dis. 2020; Li M, Dong Y, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32456948 31. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City. Obesity (Silver Spring) 2020; Hajifathalian K, Kumar S, Newberry C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470210 32. Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters. Open Forum Infect Dis 2020; 7:ofaa152Tian S, Liu H, Liao M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32457924 33. C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation. Open Forum Infect Dis 2020; 7:ofaa153Wang G, Wu C, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455147 34. COVID-19: Komorbiditäten prädisponieren für schweren Verlauf. Pneumologie 2020; 74:257Franke K. 35. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China. Stroke 2020:Strokeaha120030365Qin C, Zhou L, Hu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32466735 36. A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection. Transbound Emerg Dis 2020; Dong Y, Zhou H, Li M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469137

Safety (18 articles)

1. It is currently unknown whether SARS-CoV-2 is viable in semen or whether COVID-19 damages sperm. Andrology 2020; Perry MJ, Arrington S, Neumann LM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32471002 2. Surgical mask dermatitis caused by formaldehyde (releasers) during the COVID-19 pandemic. Contact Dermatitis 2020; Aerts O, Dendooven E, Foubert K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32468589 3. Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic - comparing a single surgical site with a COVID-19 intensive care unit. Contact Dermatitis 2020; Guertler A, Moellhoff N, Schenck TL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452036 4. Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments. Crit. Rev. Oncol. Hematol. 2020; 151:102982Jafari A, Dadkhahfar S, Perseh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460133 5. Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak. Dermatol Ther 2020; Giulia R, Alice R, Teresa FM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32447800 6. More harm than good?: COVID-19 treatment with chloroquine and hydroxychloroquine hides high risks. Deutsche Apotheker Zeitung 2020; 60Jungmayr P. 7. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020; Marfella R, Paolisso P, Sardu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447102 8. Non-steroidal anti-inflammatory drugs in management of COVID-19; a systematic review on current evidence. Int J Clin Pract 2020:e13557Yousefifard M, Zali A, Zarghi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460369 9. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis. Int J Environ Res Public Health 2020; 17Mirabelli M, Chiefari E, Puccio L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32456064 10. Ramipril in High Risk Patients with COVID-19. J Am Coll Cardiol 2020; Amat-Santos IJ, Santos-Martinez S, Lopez-Otero D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470515 11. Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring. J Am Heart Assoc 2020:e017144Ramireddy A, Chugh H, Reinier K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463348 12. Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient. J Med Virol 2020; Ma SQ, Zhang J, Wang YS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470160 13. Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia. J Med Virol 2020; Teheran AA, Camero G, Hernandez C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32458488 14. COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis. Kidney Blood Press. Res. 2020:1- 6Perna AF, Capolongo G, Trepiccione F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450560 15. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach. Life Sci 2020:117831Gurung AB, Ali MA, Lee J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450166 16. COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns. Pain Ther 2020; Pergolizzi JV, Jr., Varrassi G, Magnusson P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447629 17. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod. Biomed. Online 2020; Li R, Yin T, Fang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466994 18. [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:119- 122Gao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458599

Treatment options (79 articles)

1. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. Aaps j 2020; 22:77Sun D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458279 2. An update on ACE2 amplification and its therapeutic potential. Acta Physiol. (Oxf.) 2020:e13513Marquez A, Wysocki J, Pandit J, Batlle D. http://www.ncbi.nlm.nih.gov/pubmed/? term=32469114 3. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19. Aging (Albany NY) 2020; 12Menendez JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463794 4. Microbicidal Actives with Virucidal Efficacy against SARS-CoV-2. Am. J. Infect. Control 2020; Ijaz MK, Nims RW, Whitehead K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461067 5. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization. Biochem. Biophys. Res. Commun. 2020; Bongini P, Trezza A, Bianchini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451080 6. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines 2020; 8Glinsky GV. http://www.ncbi.nlm.nih.gov/pubmed/?term=32455629 7. Cytokine Blood Filtration Responses in COVID-19. Blood Purif. 2020:1-9Al Shareef K, Bakouri M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464624 8. Efficacy of therapeutic plasma exchange in severe COVID-19 patients. Br. J. Haematol. 2020; Zhang L, Zhai H, Ma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453903 9. Lymphopenia in COVID-19: Therapeutic Opportunities. Cell Biol. Int. 2020; Fathi N, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458561 10. A Role for Retinoids in The Treatment of Covid-19? Clin. Exp. Pharmacol. Physiol. 2020; Trasino SE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459003 11. Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials. Clin Infect Dis 2020; Raabe VN, Lighter J, Caplan AL, Ratner AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32459832 12. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review. Clin Microbiol Infect 2020; Rodrigo C, Fernando SD, Rajapakse S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470568 13. Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments. Crit. Rev. Oncol. Hematol. 2020; 151:102982Jafari A, Dadkhahfar S, Perseh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460133 14. Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy? Dermatol Ther 2020; Seirafianpour F, Mozafarpoor S, Fattahi N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473070 15. Apremilast as a potential treatment option for COVID-19: no symptoms of infection in a psoriatic patient. Dermatol Ther 2020:e13668Yu Olisova O, Anpilogova EM, Svistunova DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449265 16. TCM in the fight against COVID-19?: The traditional medicine from the Far East is expected to become an export hit, the benefit is unclear. Deutsche Apotheker Zeitung 2020; 60. 17. More harm than good?: COVID-19 treatment with chloroquine and hydroxychloroquine hides high risks. Deutsche Apotheker Zeitung 2020; 60Jungmayr P. 18. Remedy for scabies against COVID-19: In vitro efficacy of ivermectin is waiting for clinical confirmation. Deutsche Apotheker Zeitung 2020; 60Richling AI. 19. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020; Marfella R, Paolisso P, Sardu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447102 20. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis. Diabetes Metab Syndr 2020; 14:713-714Erol A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470851 21. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system. Eur Heart J Cardiovasc Pharmacother 2020; Offringa A, Montijn R, Singh S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32464637 22. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med 2020; Morena V, Milazzo L, Oreni L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448770 23. Facing SARS-CoV-2 outbreak in immunotherapy era. Future Oncol 2020; Citarella F, Russano M, Pantano F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468851 24. Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review. Infect Dis Ther 2020; Fajgenbaum DC, Khor JS, Gorzewski A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462545 25. A review on possible modes of actions of Chloroquine/ Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic. Int J Antimicrob Agents 2020:106028Tripathy S, Dassarma B, Roy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450198 26. High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. Int. J. Biol. Macromol. 2020; Naik B, Gupta N, Ojha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470577 27. Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy. Int J Infect Dis 2020; Jang S, Rhee JY. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470602 28. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification. Int J Infect Dis 2020; Wang Q, Hu Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470601 29. Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. Int J Mol Sci 2020; 21Gimeno A, Mestres-Truyol J, Ojeda-Montes MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471205 30. Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19. Int J Mol Sci 2020; 21Orienti I, Gentilomi GA, Farruggia G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471278 31. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Int J Mol Sci 2020; 21Rossi F, Tortora C, Argenziano M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471272 32. Trials and tribulations: so many potential treatments, so few answers. Int. Orthop. 2020; Gazendam A, Nucci N, Ekhtiari S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447429 33. Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy? Intern Emerg Med 2020; Depfenhart M, de Villiers D, Lemperle G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458206 34. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol. Intern Emerg Med 2020; Perotti C, Del Fante C, Baldanti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468508 35. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol 2020; Cao Y, Wei J, Zou L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470486 36. Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring. J Am Heart Assoc 2020:e017144Ramireddy A, Chugh H, Reinier K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463348 37. Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study. J Biol Regul Homeost Agents 2020; 34Marini S, Maggiorotti M, Dardes N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462858 38. Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment. J Biomol Struct Dyn 2020:1-16Ahmad S, Abbasi HW, Shahid S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462996 39. Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs. J Biomol Struct Dyn 2020:1-11Amin M, Abbas G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469265 40. In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. J Biomol Struct Dyn 2020:1-25Beura S, Prabhakar C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448039 41. Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease. J Biomol Struct Dyn 2020:1-15Choudhury C. http://www.ncbi.nlm.nih.gov/pubmed/? term=32452282 42. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. J Biomol Struct Dyn 2020:1-14de Oliveira OV, Rocha GB, Paluch AS, Costa LT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448085 43. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J Biomol Struct Dyn 2020:1-21Kumar A, Choudhir G, Shukla SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448034 44. Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn 2020:1-27Kumar V, Dhanjal JK, Bhargava P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469279 45. Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med 2020; 9Ang L, Song E, Lee HW, Lee MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32456123 46. Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect 2020; Klement-Frutos E, Burrel S, Peytavin G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473230 47. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. J Integr Med 2020; Wang SX, Wang Y, Lu YB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446813 48. COVID-19 pneumonia treated with Sarilumab: a clinical series of eight patients. J Med Virol 2020; Benucci M, Giannasi G, Cecchini P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472703 49. Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in non- hospitalized COVID-19 patients. J Med Virol 2020; Ding H, Deng W, Ding L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458502 50. Compassionate use of hzVSF-v13 in two patients with severe COVID-19. J Med Virol 2020; Kang CK, Choe PG, Park S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458425 51. Current regulatory approaches for accessing potential COVID-19 therapies. J Pharm Policy Pract 2020; 13:16Halimi V, Daci A, Stojanovska S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454981 52. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J. Intern. Med. 2020; Kang CK, Seong MW, Choi SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460458 53. The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19. Libyan J. Med. 2020; 15:1770518El Taguri A, Nasef A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32459574 54. Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19. Life Sci 2020:117842Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454157 55. Coronaviruses pandemics: Can neutralizing antibodies help? Life Sci 2020:117836Tong PB, Lin LY, Tran TH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450171 56. Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists. Med. Hypotheses 2020; 143:109871Allahverdi Khani M, SalehiRad M, Darbeheshti S, Motaghinejad M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470789 57. Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections. Med. Hypotheses 2020; 143:109866Hoang BX, Hoang HQ, Han B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473509 58. Selenium supplementation in the prevention of coronavirus infections (COVID-19). Med. Hypotheses 2020; 143:109878Kieliszek M, Lipinski B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464491 59. A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? Microb. Pathog. 2020:104277Divya M, Vijayakumar S, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473390 60. Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Nanomedicine (Lond) 2020; Uskokovic V. http://www.ncbi.nlm.nih.gov/pubmed/? term=32462968 61. Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch. Pharmacol. 2020; Aygun H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32451597 62. Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 2020; Rizzo E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462282 63. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return? Obesity (Silver Spring) 2020; Briand-Mesange F, Trudel S, Salles J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32463562 64. Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells. Pharmaceuticals (Basel) 2020; 13Lehene M, Fischer-Fodor E, Scurtu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471171 65. Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. Pharmacol. Res. 2020; 158:104901Cheong DHJ, Tan DWS, Wong FWS, Tran T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32461197 66. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol. Res. 2020:104950Viecca M, Radovanovic D, Forleo GB, Santus P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450344 67. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol. Res. 2020:104960Yuan S, Chan JFW, Chik KKH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473310 68. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacol. Ther. 2020:107587Liu T, Luo S, Libby P, Shi GP. http://www.ncbi.nlm.nih.gov/pubmed/? term=32470470 69. Cytokine storm in COVID-19 and parthenolide: preclinical evidence. Phytother. Res. 2020; Bahrami M, Kamalinejad M, Latifi SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472655 70. Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell. Res. Ther. 2020; 11:207Zhang Y, Ding J, Ren S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460839 71. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med 2020; Qu W, Wang Z, Hare JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472653 72. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike. Transfus. Apher. Sci. 2020:102794Seghatchian J, Lanza F. http://www.ncbi.nlm.nih.gov/pubmed/? term=32448638 73. COVID-19: are neutralizing antibodies neutralizing enough? Transfusion 2020; Kadkhoda K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449171 74. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis 2020:e13334Lauterio A, Valsecchi M, Santambrogio S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449235 75. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID- 19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials 2020; 21:422Wang Y, Zhou F, Zhang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448345 76. Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety. Vox Sang 2020; Epstein J, Smid M, Wendel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32464700 77. [Feasibility analysis on acupuncture therapy for the treatment of Corona Virus Disease 2019 and the exploration on the application scheme]. Zhen Ci Yan Jiu 2020; 45:345-350Wang RQ, Liu JX, Zhang ZD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447846 78. [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:119- 122Gao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458599 79. [Application of convalescent plasma therapy on novel coronavirus infection]. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43:409-413Zhao Q, He Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32450629

Trials (11 articles)

1. Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect 2020; Fragkou PC, Belhadi D, Peiffer-Smadja N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454187 2. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020; Cariou B, Hadjadj S, Wargny M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472191 3. Trials and tribulations: so many potential treatments, so few answers. Int. Orthop. 2020; Gazendam A, Nucci N, Ekhtiari S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32447429 4. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol. Intern Emerg Med 2020; Perotti C, Del Fante C, Baldanti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468508 5. Ramipril in High Risk Patients with COVID-19. J Am Coll Cardiol 2020; Amat-Santos IJ, Santos-Martinez S, Lopez-Otero D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470515 6. The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials. J Am Coll Cardiol 2020; Bagiella E, Bhatt DL, Gaudino M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470514 7. Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study. J Biol Regul Homeost Agents 2020; 34Marini S, Maggiorotti M, Dardes N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32462858 8. Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-Analyses. Trends Pharmacol Sci 2020; Ma Z, Liu J, Pan Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471655 9. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID- 19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials 2020; 21:422Wang Y, Zhou F, Zhang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32448345 10. Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial. Trials 2020; 21:416Zhang S, Lv Z, Zhu Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32446311 11. Challenges in Tuberculosis Clinical Trials in the Face of the COVID-19 Pandemic: A Sponsor's Perspective. Trop Med Infect Dis 2020; 5Rusen ID. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471274

Vaccines (4 articles) Impfstoffe

1. COVID-19 challenge: Feverish search for vaccines and antiviral therapies. Deutsche Apotheker Zeitung 2020; 160Blasius H. 2. Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics. Eur. J. Pharm. Sci. 2020:105387Ahmad S, Navid A, Farid R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32454128 3. Vaccine Rationing and the Urgency of Social Justice in the Covid-19 Response. Hastings Cent Rep 2020; Schmidt H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32468631 4. The early landscape of COVID-19 vaccine development in the UK and rest of the world. Immunology 2020; Sharpe HR, Gilbride C, Allen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460358

Women – pregnancy (27 articles) Frauen – Schwangerschaft

1. Uptrend in distress and psychiatric symptomatology in pregnant women during the COVID-19 pandemic. Acta Obstet Gynecol Scand 2020; Berthelot N, Lemieux R, Garon-Bissonnette J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449178 2. Age-related difference in the rate of COVID-19 mortality in women versus men. Am J Obstet Gynecol 2020; Cagnacci A, Xholli A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460973 3. COVID-19: Safe Guidelines for Breast Imaging During the Pandemic. Can Assoc Radiol J 2020:846537120928864Seely JM, Scaranelo AM, Yong-Hing C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32452700 4. Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington. Clin Infect Dis 2020; LaCourse SM, Kachikis A, Blain M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472688 5. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). Clin Infect Dis 2020; Tam PCK, Ly KM, Kernich ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472683 6. A new diagnostic strategy for gestational diabetes during the COVID-19 pandemic for the Japanese population. Diabetes Metab Res Rev 2020:e3351Kasuga Y, Saisho Y, Ikenoue S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32453497 7. Diabetes and pregnancy—update 2020. Diabetologe 2020; Kleinwechter H. 8. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? Eur. J. Contracept. Reprod. Health Care 2020:1-2Grandi G, Facchinetti F, Bitzer J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32469251 9. Management of a delivery suite during the COVID-19 epidemic. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; Qi H, Chen M, Luo X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466867 10. Challenges and solutions for maternity and gynecology services during the COVID-19 crisis in Jordan. Int J Gynaecol Obstet 2020; Alsharaydeh I, Rawashdeh H, Saadeh N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32470178 11. Practical recommendations for gynecologic surgery during the COVID-19 pandemic. Int J Gynaecol Obstet 2020; Chiofalo B, Baiocco E, Mancini E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471012 12. Maternal mortality from COVID-19 in Mexico. Int J Gynaecol Obstet 2020; Lumbreras-Marquez MI, Campos-Zamora M, Lizaola-Diaz de Leon H, Farber MK. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473603 13. Healthcare information on YouTube: Pregnancy and COVID-19. Int J Gynaecol Obstet 2020; Yuksel B, Cakmak K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32471005 14. Gynecologic oncology at the time of COVID-19 outbreak. J Gynecol Oncol 2020; Bogani G, Brusadelli C, Guerrisi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458597 15. Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists. J Gynecol Oncol 2020; Wang Y, Zhang S, Wei L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458596 16. Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond. J. Natl. Cancer Inst. 2020; Freedman RA, Sedrak MS, Bellon JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32449757 17. COVID-19 and pregnancy - where are we now? A review. J. Perinat. Med. 2020; Rajewska A, Mikolajek- Bedner W, Lebdowicz-Knul J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32452195 18. SARS-CoV-2 and human milk: What is the evidence? Matern. Child Nutr. 2020:e13032Lackey KA, Pace RM, Williams JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32472745 19. COVID-19, food and nutrition insecurity and the wellbeing of children, pregnant and lactating women: A complex syndemic. Matern. Child Nutr. 2020:e13036Perez-Escamilla R, Cunningham K, Moran VH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458574 20. When Separation is not the Answer: Breastfeeding Mothers and Infants affected by COVID-19. Matern. Child Nutr. 2020:e13033Tomori C, Gribble K, Palmquist AEL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458558 21. COVID-19 and fertility: a virtual reality. Reprod. Biomed. Online 2020; Anifandis G, Messini CI, Daponte A, Messinis IE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466995 22. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod. Biomed. Online 2020; Li R, Yin T, Fang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32466994 23. A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy. Reprod. Biomed. Online 2020; Requena A, Cruz M, Vergara V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32451301 24. [Coronavirus Covid-19 infection and breastfeeding: an exploratory review]. Rev. Esp. Salud Publica 2020; 94Fernandez-Carrasco FJ, Vazquez-Lara JM, Gonzalez-Mey U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32458823 25. Access to later abortion in the United States during COVID-19: Challenges and recommendations from providers, advocates, and researchers. Sex Reprod Health Matters 2020:1-4Ruggiero S, Brandi K, Mark A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32460663 26. Screening for COVID-19 at childbirth: does it deliver? Ultrasound Obstet Gynecol 2020; Ceulemans D, Thijs I, Schreurs A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449230 27. Prevention of thrombosis in pregnant women with suspected SARS-CoV-2 infection: clinical management algorithm. Ultrasound Obstet Gynecol 2020; Lou-Mercade AC, Gavin O, Oros D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32449242

to subscribe click here